Motif ID	Motif Logo	Scanned Score Distribution	Frequency of Motif	Replicability Score	Evolutionary Conservation Score	Gene Targets	Gene Ontology of CpGMM targets
CG_ff_promoter_n_RM_16_13_2			1	0.5	2.84E-04	TDP2, MAP4K1	5'-tyrosyl-DNA phosphodiesterase activity [MF], MAP kinase kinase kinase kinase activity [MF], tyrosyl-RNA phosphodiesterase activity [MF]
CG_ff_promoter_n_RM_12_204_9			1	0.5	2.10E-04	TGM2, KEAP1	proteasomal ubiquitin-independent protein catabolic process [BP], isopeptide cross-linking via N6-(L-isoglutamyl)-L-lysine [BP]
CG_ff_promoter_n_RM_12_185_14			4	0.5	3.78E-04	CDK5, CDK6, HMGB1	cyclin-dependent protein kinase holoenzyme complex [CC], neuron projection development [BP]
CG_ff_promoter_n_RM_12_399_9			2	0.5	2.59E-04	TBX3, MYO1C, NRIP1, PAX5, ENO1, PER1, TBX18, AKT2, MKX, NKX6-1, DVL2	negative regulation of transcription from RNA polymerase II promoter [BP], segment specification [BP], negative regulation of transcription, DNA-dependent [BP], sinoatrial node development [BP], negative regulation of myoblast differentiation [BP], positive regulation of protein targeting to membrane [BP]
CG_ff_promoter_n_RM_12_37_15			3	0.5	3.48E-04	EXT1	cellular polysaccharide biosynthetic process [BP]
CG_ff_promoter_n_RM_12_344_4			2	0.5	1.61E-04	NUDT3, LBX1, XPA	diphosphoinositol polyphosphate catabolic process [BP], intrinsic apoptotic signaling pathway in response to DNA damage [BP], regulation of transcription from RNA polymerase II promoter involved in spinal cord association neuron specification [BP], diadenosine polyphosphate catabolic process [BP]
CG_ff_promoter_n_RM_12_73_16			4	1.0	7.04E-05	TTPA	negative regulation of establishment of blood-brain barrier [BP], vitamin E binding [MF]
CG_ff_promoter_n_RM_12_136_8			2	1.0	1.41E-04	DEAF1, CELF4	germ cell development [BP]
CG_ff_promoter_n_RM_16_19_1			1	0.5	5.02E-05	TRPT1	tRNA 2'-phosphotransferase activity [MF]
CG_ff_promoter_n_RM_12_87_5			1	0.5	1.86E-04	SNCB, INO80, BNIP3, FOXA1	alpha-tubulin binding [MF], cellular response to cobalt ion [BP], positive regulation of DNA replication involved in S phase [BP], chromatin remodeling [BP]
CG_ff_promoter_n_RM_12_317_11			2	1.0	1.88E-04	FLOT2, MSL2	flotillin complex [CC], MSL complex [CC]
CG_ff_promoter_n_RM_12_159_9			2	0.5	2.26E-04	DMRTA2, LMO2, NFYB, KLF4, MAFB, YPEL1	transcription factor complex [CC], negative regulation of erythrocyte differentiation [BP], RNA polymerase II transcription factor binding transcription factor activity involved in positive regulation of transcription [MF], negative regulation of protein kinase B signaling cascade [BP], sequence-specific DNA binding [MF]
CG_ff_promoter_n_RM_12_33_8			1	0.5	2.19E-04	DAB1	cell-cell adhesion involved in neuronal-glial interactions involved in cerebral cortex radial glia guided migration [BP]
CG_ff_promoter_n_RM_12_85_6			1	0.5	1.47E-04	PPP3CA	transition between fast and slow fiber [BP]
CG_ff_promoter_n_RM_12_35_8			2	0.5	1.62E-04	MB21D1	cyclic-GMP-AMP synthase activity [MF]
CG_ff_promoter_n_RM_12_134_9			1	0.5	2.25E-04	HNRNPD, PCID2	regulation of mRNA stability [BP]
CG_ff_promoter_n_RM_12_40_8			3	0.5	2.85E-04	LMF1, ARFGEF1, KRIT1	regulation of establishment of cell polarity [BP], protein glycosylation in Golgi [BP]
CG_ff_promoter_n_RM_12_367_8			2	0.5	2.62E-04	UROC1, YBX2, GOT1	urocanate hydratase activity [MF], glutamate metabolic process [BP], translational attenuation [BP]
CG_ff_promoter_n_RM_14_97_4			2	0.5	3.63E-04	TRPM7	calcium-dependent cell-matrix adhesion [BP]
CG_ff_promoter_n_RM_12_46_13			3	0.5	1.91E-04	NUPR1, BCL11A, ULK2	regulation of female gonad development [BP], negative regulation of collateral sprouting [BP]
CG_ff_promoter_n_RM_12_345_13			2	0.5	2.34E-04	HOXA5	regulation of mammary gland epithelial cell proliferation [BP]
CG_ff_promoter_n_RM_18_13_1			1	0.5	3.93E-04	TNFRSF10D, PITX1	TRAIL binding [MF], myoblast cell fate commitment [BP], branchiomeric skeletal muscle development [BP]
CG_ff_promoter_n_RM_14_51_2			2	0.5	3.87E-04	ABCB6, NCAPD3, DBN1	heme-transporting ATPase activity [MF], cell communication by chemical coupling [BP], nuclear condensin complex [CC]
CG_ff_promoter_n_RM_12_233_18			3	0.5	3.09E-04	DEGS2, LSG1, ELL, UCN	sphingolipid delta-4 desaturase activity [MF], Cajal body [CC], gastric emptying [BP], sphingosine hydroxylase activity [MF]
CG_ff_promoter_n_RM_12_302_20			4	0.5	2.38E-04	MCM3, MMS22L, CCNE2	MCM complex [CC], DNA replication initiation [BP], nuclear replication fork [CC]
CG_ff_promoter_n_RM_12_369_11			3	0.5	4.48E-04	CASP3, FGFR1, FZD4	sensory perception of sound [BP]
CG_ff_promoter_n_RM_12_300_12			2	0.5	4.10E-04	GCNT4, DNAJB8, WNT3, SDC1, SCYL3, TBCA, ITGA7, HOXA7, DLL1, CELSR1, FKBP1A, TUBA4A, CYP26B1, HLA-DMA, TOR2A, WNT11, WNT7B, SMURF1	Wnt receptor signaling pathway [BP], chaperone mediated protein folding requiring cofactor [BP], activin binding [MF], 'de novo' protein folding [BP], loop of Henle development [BP], non-canonical Wnt receptor signaling pathway [BP], cell migration [BP], lung-associated mesenchyme development [BP], embryonic organ development [BP], inner ear development [BP], anterior/posterior pattern specification [BP], tissue morphogenesis [BP], protein folding [BP], canonical Wnt receptor signaling pathway [BP], 'de novo' posttranslational protein folding [BP], axis specification [BP], cellular response to retinoic acid [BP]
CG_ff_promoter_n_RM_12_341_4			1	0.5	2.60E-04	SOX30	sequence-specific DNA binding RNA polymerase II transcription factor activity [MF]
CG_ff_promoter_n_RM_12_362_12			1	0.5	1.83E-04	FLT1, DUSP16	vascular endothelial growth factor receptor-1 signaling pathway [BP], MAPK export from nucleus [BP], MAPK phosphatase export from nucleus, leptomycin B sensitive [BP], placental growth factor-activated receptor activity [MF], VEGF-B-activated receptor activity [MF], VEGF-A-activated receptor activity [MF]
CG_ff_promoter_n_RM_16_18_14			2	0.5	4.23E-04	GTF2E2, ZZZ3, SOS2, PJA2, PRPF19, EVX2, GSK3B, ZER1, CSRNP1, ZNF367, TCEA1, MLL3, TAF11, DNAJC1, NKX3-2, CUL3, POLR2I, LCORL, CUL2, TOP2A, ZBTB2	transcription elongation from RNA polymerase II promoter [BP], protein kinase A catalytic subunit binding [MF], Cul2-RING ubiquitin ligase complex [CC], DNA binding [MF], transcription from RNA polymerase II promoter [BP], embryonic cleavage [BP]
CG_ff_promoter_n_RM_12_81_7			1	0.5	4.27E-05	WARS, CBS	cystathionine beta-synthase activity [MF], L-serine catabolic process [BP], cysteine biosynthetic process via cystathionine [BP], tryptophanyl-tRNA aminoacylation [BP], homocysteine catabolic process [BP], transsulfuration [BP], cysteine biosynthetic process from serine [BP], hydrogen sulfide biosynthetic process [BP], L-cysteine catabolic process [BP], tryptophan-tRNA ligase activity [MF]
CG_ff_promoter_n_RM_14_95_6			3	0.5	3.94E-04	NRL, SLC35B2	positive regulation of rhodopsin gene expression [BP], 3'-phosphoadenosine 5'-phosphosulfate transport [BP], 3'-phosphoadenosine 5'-phosphosulfate transmembrane transporter activity [MF]
CG_ff_promoter_n_RM_12_83_6			1	0.5	1.67E-04	MTOR	regulation of carbohydrate utilization [BP], mTOR-FKBP12-rapamycin complex [CC]
CG_ff_promoter_n_RM_14_99_3			3	0.5	1.12E-04	PIEZO1, CARS2	cysteinyl-tRNA aminoacylation [BP], mechanically-gated ion channel activity [MF], cysteine-tRNA ligase activity [MF]
CG_ff_promoter_n_RM_20_4_1			2	1.0	9.37E-05	ABCB11, VPS33B, CALCA	calcitonin receptor binding [MF], canalicular bile acid transmembrane transporter activity [MF], bile acid-exporting ATPase activity [MF], platelet alpha granule organization [BP], vasodilation of artery involved in baroreceptor response to increased systemic arterial blood pressure [BP], sodium-exporting ATPase activity, phosphorylative mechanism [MF]
CG_ff_promoter_n_RM_12_306_8			2	0.5	2.88E-04	FOXA2, POU4F1	neuron fate specification [BP]
CG_ff_promoter_n_RM_12_61_3			1	0.5	1.77E-04	EDN2, CGB1, FNDC5	hormonal regulation of the force of heart contraction [BP], hormone activity [MF]
CG_ff_promoter_n_RM_12_311_12			2	0.5	2.85E-04	GDI2, WNT11, FGFR1, RASGEF1C	regulation of small GTPase mediated signal transduction [BP], lung-associated mesenchyme development [BP]
CG_ff_promoter_n_RM_12_19_5			1	0.5	4.41E-04	SLC25A29, ASNS, NES, SLC33A1, TNPO3	acetyl-CoA transporter activity [MF], acetyl-CoA transport [BP], acyl carnitine transmembrane transporter activity [MF], L-asparagine biosynthetic process [BP], positive regulation of intermediate filament depolymerization [BP], splicing factor protein import into nucleus [BP]
CG_ff_promoter_n_RM_12_424_8			2	1.0	1.71E-04	DDB1, MYO1C, HRAS, ST3GAL5, ERCC2	neolactotetraosylceramide alpha-2,3-sialyltransferase activity [MF], nucleotide-excision repair, DNA damage removal [BP], lactosylceramide alpha-2,3-sialyltransferase activity [MF], myosin I complex [CC], protein C-terminus binding [MF]
CG_ff_promoter_n_RM_12_245_8			3	0.5	2.97E-04	VPS36	ubiquitin binding [MF]
CG_ff_promoter_n_RM_12_5_5			4	0.5	2.32E-04	NOP14, CEBPA	Noc4p-Nop14p complex [CC], response to vitamin B2 [BP]
CG_ff_promoter_n_RM_12_368_8			2	0.5	2.19E-04	CDK5, DVL1	receptor clustering [BP]
CG_ff_promoter_n_RM_12_374_10			3	0.5	2.25E-04	LRP8, GIP, SLC4A11	ammon gyrus development [BP], phosphoenolpyruvate-dependent sugar phosphotransferase system [BP], borate transmembrane transporter activity [MF], borate transport [BP], fluid transport [BP], borate transmembrane transport [BP], positive regulation of glucagon secretion [BP]
CG_ff_promoter_n_RM_14_58_2			1	0.5	2.00E-04	SLC35B2, RANGAP1, KDSR	3'-phosphoadenosine 5'-phosphosulfate transport [BP], positive regulation of Ran GTPase activity [BP], Ran GTPase activator activity [MF], 3-dehydrosphinganine reductase activity [MF], 3-keto-sphinganine metabolic process [BP], 3'-phosphoadenosine 5'-phosphosulfate transmembrane transporter activity [MF]
CG_ff_promoter_n_RM_12_172_9			3	0.5	2.61E-04	SLC9A1, SLC23A1	transepithelial L-ascorbic acid transport [BP], sodium ion export [BP], sodium ion transmembrane transport [BP], dehydroascorbic acid transport [BP], L-ascorbic acid transport [BP]
CG_ff_promoter_n_RM_12_325_8			2	0.5	1.33E-04	VDR, TK2, MEFV	vitamin D3 receptor activity [MF], negative regulation of macrophage inflammatory protein 1 alpha production [BP], deoxycytidine metabolic process [BP]
CG_ff_promoter_n_RM_12_393_12			3	0.5	2.58E-04	NFE2L2, CTTNBP2, CTBP1, SH3GL1, SLC30A3, DOC2B	protein domain specific binding [MF], synaptic vesicle [CC]
CG_ff_promoter_n_RM_12_408_9			2	0.5	1.16E-04	FASN, POT1, HYI	3-hydroxypalmitoyl-[acyl-carrier-protein] dehydratase activity [MF], positive regulation of DNA strand elongation [BP], 3-hydroxyoctanoyl-[acyl-carrier-protein] dehydratase activity [MF], enoyl-[acyl-carrier-protein] reductase (NADPH, B-specific) activity [MF], [acyl-carrier-protein] S-acetyltransferase activity [MF], hydroxypyruvate isomerase activity [MF], 3-oxoacyl-[acyl-carrier-protein] reductase (NADPH) activity [MF]
CG_ff_promoter_n_RM_12_269_22			2	0.5	4.82E-04	PPP2CA, HOXB3, HOXB5, TWIST1, SSH2, WAPAL, DUSP4, GAS1, SMEK1, PTPRK, RAD21	protein dephosphorylation [BP], outer ear morphogenesis [BP], protein localization to chromatin [BP], embryonic skeletal system morphogenesis [BP]
CG_ff_promoter_n_RM_12_372_22			4	0.5	2.74E-04	TWIST1	cranial suture morphogenesis [BP]
CG_ff_promoter_n_RM_12_6_10			4	0.5	1.98E-04	CTBP1	oxidoreductase activity, acting on the CH-OH group of donors, NAD or NADP as acceptor [MF]
CG_ff_promoter_n_RM_12_48_14			3	0.5	1.83E-04	IFT57, RP1L1	photoreceptor connecting cilium [CC]
CG_ff_promoter_n_RM_12_217_20			2	0.5	4.12E-04	HOXA2	segment specification [BP]
CG_ff_promoter_n_RM_12_69_6			1	0.5	2.58E-04	BCL9L, GDNF, NACC2	negative regulation of G1/S transition of mitotic cell cycle by negative regulation of transcription from RNA polymerase II promoter [BP], regulation of cell morphogenesis [BP], postganglionic parasympathetic nervous system development [BP]
CG_ff_promoter_n_RM_12_29_19			3	0.5	2.02E-04	PKM, HDAC4	potassium ion binding [MF]
CG_ff_promoter_n_RM_12_163_17			2	0.5	3.13E-04	ERCC3, SOS1, PITPNA, NOC2L, NSUN2, FGFR2, LATS2, SFRP1, CDK5, RAF1, ADA, PITX2, MAK, RHOG, SPC24, PSPN	digestive tract development [BP], hair cell differentiation [BP], prostate epithelial cord arborization involved in prostate glandular acinus morphogenesis [BP], branching involved in prostate gland morphogenesis [BP], negative regulation of B cell apoptotic process [BP], embryonic digestive tract development [BP], protein kinase activity [MF], digestive tract morphogenesis [BP], regulation of branching involved in prostate gland morphogenesis [BP], endodermal digestive tract morphogenesis [BP], axon guidance [BP], multicellular organismal development [BP], cell division [BP]
CG_ff_promoter_n_RM_12_15_9			4	1.0	1.30E-04	SLC12A6, OCA2, COBL	L-tyrosine transmembrane transporter activity [MF], arsenite transport [BP], cellular hypotonic salinity response [BP], tyrosine transport [BP], actin filament network formation [BP]
CG_ff_promoter_n_RM_12_157_10			2	0.5	2.29E-04	TP53BP2, GSK3B, WNK3	NF-kappaB binding [MF], positive regulation of peptidyl-threonine phosphorylation [BP]
CG_ff_promoter_n_RM_14_8_14			3	0.5	4.49E-04	RUNX1, SP3	definitive hemopoiesis [BP]
CG_ff_promoter_n_RM_12_63_3			1	0.5	1.77E-04	ANXA11, PRDM14, NKX2-2	ventral spinal cord interneuron fate determination [BP], cytokinesis, completion of separation [BP], cell fate specification [BP], pancreatic A cell fate commitment [BP], type B pancreatic cell fate commitment [BP], pancreatic PP cell fate commitment [BP]
CG_ff_promoter_n_RM_12_397_16			2	0.5	1.17E-04	HLCS	biotin-protein ligase activity [MF], biotin-[methylcrotonoyl-CoA-carboxylase] ligase activity [MF], biotin-[methylmalonyl-CoA-carboxytransferase] ligase activity [MF], protein biotinylation [BP], biotin-[acetyl-CoA-carboxylase] ligase activity [MF], biotin-[propionyl-CoA-carboxylase (ATP-hydrolyzing)] ligase activity [MF], histone biotinylation [BP]
CG_ff_promoter_n_RM_12_176_8			1	0.5	1.95E-04	SLC23A1	dehydroascorbic acid transport [BP]
CG_ff_promoter_n_RM_12_287_8			1	0.5	2.71E-04	IRS2, TBX18	negative regulation of canonical Wnt receptor signaling pathway involved in neural plate anterior/posterior pattern formation [BP], positive regulation of mesenchymal cell proliferation [BP]
CG_ff_promoter_n_RM_14_79_8			4	0.5	4.25E-04	CACNA2D2	positive regulation of organ growth [BP]
CG_ff_promoter_n_RM_12_67_8			2	0.5	2.65E-04	POLE, GP2, MCM7	antigen transcytosis by M cells in mucosal-associated lymphoid tissue [BP], DNA replication initiation [BP]
CG_ff_promoter_n_RM_14_60_2			2	0.5	7.90E-05	UROC1, HDDC3, SRD5A2	urocanate hydratase activity [MF], sterol 5-alpha reductase activity [MF], guanosine-3',5'-bis(diphosphate) 3'-diphosphatase activity [MF]
CG_ff_promoter_n_RM_16_16_11			2	0.5	4.39E-04	BCL11A, HIRA, CBX4	transcription corepressor activity [MF]
CG_ff_promoter_n_RM_12_17_3			2	0.5	3.41E-04	NKX3-2	embryonic skeletal system development [BP]
CG_ff_promoter_n_RM_12_203_14			3	0.5	3.21E-04	ENTPD5	protein N-linked glycosylation [BP]
CG_ff_promoter_n_RM_12_52_6			1	0.5	2.86E-05	PGAM2, NR4A2	habenula development [BP], 2,3-bisphosphoglycerate-dependent phosphoglycerate mutase activity [MF]
CG_ff_promoter_n_RM_14_72_3			3	0.5	2.49E-04	SALL1, CCT8L2, TJP1	anion channel activity [MF], inductive cell-cell signaling [BP], cell-cell signaling involved in cell-cell junction organization [BP]
CG_ff_promoter_n_RM_12_205_4			2	0.5	1.73E-04	ADAMTS2, COL2A1	collagen type II [CC], collagen fibril organization [BP]
CG_ff_promoter_n_RM_16_10_1			1	0.5	8.92E-05	ZNF709, ZNF44, ZNF442, ZNF433, ZNF823	transcription, DNA-dependent [BP], DNA binding [MF], regulation of transcription, DNA-dependent [BP], zinc ion binding [MF]
CG_ff_promoter_n_RM_12_289_8			2	0.5	2.23E-04	ACTL6B, PPL, REV3L	structural constituent of cytoskeleton [MF], zeta DNA polymerase complex [CC]
CG_ff_promoter_n_RM_12_391_11			2	0.5	2.95E-04	RANGAP1, IRS2, BARD1, AKT1	negative regulation of plasma membrane long-chain fatty acid transport [BP], positive regulation of glycogen biosynthetic process [BP], positive regulation of glucose metabolic process [BP], negative regulation of protein export from nucleus [BP]
CG_ff_promoter_n_RM_12_9_4			1	0.5	2.82E-04	GFPT1, SYNE4, ADRA1A	integral to nuclear outer membrane [CC], negative regulation of heart rate involved in baroreceptor response to increased systemic arterial blood pressure [BP], glucosamine biosynthetic process [BP]
CG_ff_promoter_n_RM_12_320_8			3	0.5	3.74E-04	SIX2, SALL1, MAF, NKX2-2, IRX2, MEIS3	mesenchymal to epithelial transition involved in metanephros morphogenesis [BP], kidney epithelium development [BP], sequence-specific DNA binding [MF]
CG_ff_promoter_n_RM_14_70_4			2	0.5	1.46E-04	RAB3A	maintenance of presynaptic active zone structure [BP], response to electrical stimulus [BP]
CG_ff_promoter_n_RM_12_268_9			2	0.5	2.80E-04	CDK6, NCKAP1, DLL1	embryonic heart tube development [BP], negative regulation of myeloid cell differentiation [BP], somitogenesis [BP], cell dedifferentiation [BP]
CG_ff_promoter_n_RM_12_222_6			1	0.5	2.62E-04	SYCE3, SYCE2, MKX, TBX20	RNA polymerase II transcription factor binding [MF], central element [CC]
CG_ff_promoter_n_RM_14_76_5			4	0.5	1.53E-04	MAP3K6, MAP3K7, LSM4	MAP kinase kinase kinase activity [MF], U6 snRNP [CC]
CG_ff_promoter_n_RM_12_405_7			1	0.5	2.91E-04	DDX6, PABPC1	cytoplasmic stress granule [CC]
CG_ff_promoter_n_RM_20_9_1			1	0.5	2.68E-04	MAGEC2, NT5C2, ADA, DAXX	negative regulation of mucus secretion [BP], negative regulation of adenosine receptor signaling pathway [BP], negative regulation of penile erection [BP], dATP catabolic process [BP], germinal center B cell differentiation [BP], ubiquitin protein ligase binding [MF], negative regulation of circadian sleep/wake cycle, non-REM sleep [BP], xanthine biosynthetic process [BP], purine nucleobase metabolic process [BP], deoxyadenosine catabolic process [BP], nucleoside phosphotransferase activity [MF]
CG_ff_promoter_n_RM_14_27_6			3	0.5	5.17E-04	BCL6, HOXB3, AMER2, BCL11A, PARD3, HOXA7, KLF10, CBX4, ZNF746	negative regulation of transcription from RNA polymerase II promoter [BP], protein sumoylation [BP], negative regulation of cell-matrix adhesion [BP], negative regulation of transcription, DNA-dependent [BP], phosphatidylinositol-4,5-bisphosphate binding [MF], negative regulation of gene expression [BP], hemopoiesis [BP]
CG_ff_promoter_n_RM_12_16_13			2	0.5	5.04E-04	SP3, CTBP1	transcriptional repressor complex [CC], regulation of transcription by chromatin organization [BP]
CG_ff_promoter_n_RM_12_407_8			2	0.5	1.78E-04	ICMT, TBX3	atrioventricular bundle cell differentiation [BP], sinoatrial node cell development [BP], protein C-terminal S-isoprenylcysteine carboxyl O-methyltransferase activity [MF]
CG_ff_promoter_n_RM_20_7_2			1	0.5	9.36E-06	LRPAP1	rough endoplasmic reticulum lumen [CC], low-density lipoprotein particle receptor binding [MF], asialoglycoprotein receptor activity [MF], lipase binding [MF], negative regulation of beta-amyloid clearance [BP], extracellular negative regulation of signal transduction [BP], receptor antagonist activity [MF], very-low-density lipoprotein particle receptor binding [MF], negative regulation of very-low-density lipoprotein particle clearance [BP]
CG_ff_promoter_n_RM_12_360_7			2	1.0	2.66E-05	LRPAP1, CNR2, IL12B, SFRP2	negative regulation of dermatome development [BP], metalloenzyme activator activity [MF], interleukin-12 alpha subunit binding [MF], rough endoplasmic reticulum lumen [CC], regulation of stem cell division [BP], interleukin-12 complex [CC], interleukin-23 receptor binding [MF], negative regulation of inflammatory response [BP], interleukin-23 complex [CC]
CG_ff_promoter_n_RM_12_403_11			2	0.5	2.15E-04	PRICKLE1, RCHY1	positive regulation of proteasomal ubiquitin-dependent protein catabolic process [BP]
CG_ff_promoter_n_RM_12_386_12			2	0.5	3.90E-04	KIFC3, KIF17	kinesin complex [CC]
CG_ff_promoter_n_RM_12_45_9			4	0.5	1.54E-04	EXOSC10	nuclear retention of unspliced pre-mRNA at the site of transcription [BP]
CG_ff_promoter_n_RM_12_215_12			2	0.5	1.46E-04	IL6ST, GLI3, STRA13, FANCC, TOP2B, ACVR1	Fanconi anaemia nuclear complex [CC], resolution of meiotic recombination intermediates [BP], positive regulation of osteoblast differentiation [BP]
CG_ff_promoter_n_RM_12_388_18			3	0.5	2.13E-04	TNFRSF21, GFRA1, HOXA5, SSBP3	head morphogenesis [BP], prechordal plate formation [BP], cell-cell signaling involved in mammary gland development [BP], midbrain-hindbrain boundary initiation [BP], axon [CC]
CG_ff_promoter_n_RM_12_95_10			4	1.0	8.38E-05	NKX3-1, CCL5, AAMP	smooth muscle cell migration [BP], protein self-association [MF], protein binding transcription factor activity [MF]
CG_ff_promoter_n_RM_12_32_6			3	0.5	1.19E-05	TTLL1, SLC38A7	L-asparagine transmembrane transporter activity [MF], L-leucine transmembrane transporter activity [MF], tubulin-glutamic acid ligase activity [MF], L-methionine transmembrane transporter activity [MF], L-histidine transmembrane transporter activity [MF]
CG_ff_promoter_n_RM_12_34_8			2	0.5	2.25E-04	SFRP4, AKT1	negative regulation of JNK cascade [BP], maternal placenta development [BP]
CG_ff_promoter_n_RM_12_324_4			2	0.5	1.98E-04	NODAL, AKR7A3, PDGFC, TGFA	transforming growth factor beta receptor signaling pathway involved in primitive streak formation [BP], epiblast cell-extraembryonic ectoderm cell signaling involved in anterior/posterior axis specification [BP], axial mesodermal cell fate specification [BP], aflatoxin catabolic process [BP], inhibition of neuroepithelial cell differentiation [BP], growth factor activity [MF]
CG_ff_promoter_n_RM_12_41_6			3	0.5	3.18E-04	YWHAG, GIPC1	regulation of synaptic plasticity [BP]
CG_ff_promoter_n_RM_12_135_6			1	0.5	1.19E-04	RYBP, CNTFR, DLX5, CBX4, CRYGD, SCN5A	brainstem development [BP], lens fiber cell differentiation [BP], positive regulation of epithelial cell proliferation [BP], PcG protein complex [CC]
CG_ff_promoter_n_RM_14_14_5			3	0.5	3.09E-04	DRD1, SLC6A20	glycine transport [BP], sensitization [BP]
CG_ff_promoter_n_RM_12_38_8			2	0.5	3.43E-04	WNT11, PTCH1	heart morphogenesis [BP], axis specification [BP]
CG_ff_promoter_n_RM_14_56_3			2	0.5	3.90E-04	PGAM2, NACC2	negative regulation of G1/S transition of mitotic cell cycle by negative regulation of transcription from RNA polymerase II promoter [BP], 2,3-bisphosphoglycerate-dependent phosphoglycerate mutase activity [MF]
CG_ff_promoter_n_RM_12_363_6			2	0.5	5.58E-05	TEFM, NPY1R	pancreatic polypeptide receptor activity [MF], DNA polymerase processivity factor activity [MF]
CG_ff_promoter_n_RM_12_412_14			2	0.5	4.65E-04	ONECUT1, OTX2, TRPT1, ARVCF, UCN	tRNA 2'-phosphotransferase activity [MF], multicellular organismal development [BP], RNA polymerase II core promoter proximal region sequence-specific DNA binding transcription factor activity involved in positive regulation of transcription [MF], endoderm development [BP], gastric emptying [BP]
CG_ff_promoter_n_RM_12_60_12			1	0.5	2.39E-04	QRFP, CYTL1, MCEE, CEBPA	orexigenic neuropeptide QRFP receptor binding [MF], methylmalonyl-CoA epimerase activity [MF], inner ear development [BP]
CG_ff_promoter_n_RM_14_16_5			3	0.5	4.03E-04	UBC	female gonad development [BP]
CG_ff_promoter_n_RM_12_238_10			4	0.5	4.35E-04	ERBB4, PDK4, JAK3	response to interleukin-9 [BP], protein tyrosine kinase activity [MF], tyrosine phosphorylation of STAT protein [BP], protein kinase activity [MF], central nervous system morphogenesis [BP], negative regulation of apoptotic process [BP], STAT protein import into nucleus [BP], cardiac muscle tissue regeneration [BP], negative regulation of FasL biosynthetic process [BP], transmembrane receptor protein tyrosine kinase signaling pathway [BP], negative regulation of dendritic cell cytokine production [BP]
CG_ff_promoter_n_RM_12_314_18			2	0.5	2.56E-04	DNAJC1, TUBB4A	protein folding [BP]
CG_ff_promoter_n_RM_12_343_12			3	0.5	4.12E-04	FZD5, SCRIB	establishment of apical/basal cell polarity [BP], apoptotic process involved in morphogenesis [BP]
CG_ff_promoter_n_RM_12_202_8			2	0.5	3.08E-04	RBBP7, EPHA2, ACD, ACSS1	notochord cell development [BP], acetate biosynthetic process [BP], cellular heat acclimation [BP], positive regulation of single-stranded telomeric DNA binding [BP], propionate biosynthetic process [BP]
CG_ff_promoter_n_RM_14_37_6			4	1.0	2.98E-04	MGEA5	negative regulation of cardiac muscle adaptation [BP]
CG_ff_promoter_n_RM_12_121_15			2	1.0	2.16E-04	JAK1, HLA-DQB1	interferon-gamma-mediated signaling pathway [BP]
CG_ff_promoter_n_RM_12_114_10			2	1.0	3.37E-05	ARSA	cerebroside-sulfatase activity [MF]
CG_ff_promoter_n_RM_12_226_18			2	0.5	3.01E-04	ECE1, CTSH	bradykinin catabolic process [BP], neuropeptide catabolic process [BP]
CG_ff_promoter_n_RM_14_10_3			5	1.0	2.60E-04	EN1, HDAC2, MAPK11, NEUROD2, DVL2	hindbrain development [BP], regulation of sequence-specific DNA binding transcription factor activity [BP], positive regulation of sequence-specific DNA binding transcription factor activity [BP]
CG_ff_promoter_n_RM_12_42_4			1	0.5	2.16E-04	PLOD3	procollagen glucosyltransferase activity [MF]
CG_ff_promoter_n_RM_12_30_4			2	1.0	2.91E-04	KCNJ11, LRP6, NT5C1A, SOS1, AP2S1, ADAM10, MACROD1, HMGCS1	epidermal growth factor receptor signaling pathway [BP], nucleoside metabolic process [BP], cellular response to cholesterol [BP], small molecule metabolic process [BP], purine nucleoside metabolic process [BP]
CG_ff_promoter_n_RM_12_301_6			4	0.5	2.63E-04	KDSR, PRKACA, RANGAP1, PHYH, EGR2	rhombomere 3 formation [BP], rhombomere 5 formation [BP], Ran GTPase activator activity [MF], protein export from nucleus [BP], 3-dehydrosphinganine reductase activity [MF], regulation of synaptic transmission [BP], phytanoyl-CoA dioxygenase activity [MF], 3-keto-sphinganine metabolic process [BP], positive regulation of Ran GTPase activity [BP]
CG_ff_promoter_n_RM_12_191_10			2	0.5	2.73E-04	STK10, PDF, TMEM184A	lymphocyte aggregation [BP], polo kinase kinase activity [MF], peptide deformylase activity [MF], germ-line sex determination [BP]
CG_ff_promoter_n_RM_12_266_11			2	0.5	3.87E-04	TSHZ3, STAT5B, ZIC5, ZXDC, PAX3, ADAM17, POU2F2, ANPEP, ASCL2	central nervous system development [BP], B cell differentiation [BP], cell differentiation [BP], sequence-specific DNA binding transcription factor activity [MF]
CG_ff_promoter_n_RM_12_348_8			1	0.5	5.22E-05	ADAMTS8	low affinity phosphate transmembrane transporter activity [MF]
CG_ff_promoter_n_RM_14_3_2			1	0.5	3.19E-04	TLN1, EPHA2	notochord cell development [BP], ruffle membrane [CC]
CG_ff_promoter_n_RM_14_39_4			3	0.5	2.44E-04	RPS6, HLCS, IRS1, FOXA1	protein biotinylation [BP], glucose homeostasis [BP], histone biotinylation [BP]
CG_ff_promoter_n_RM_12_231_13			2	0.5	1.44E-04	EIF3A	formation of translation initiation complex [BP]
CG_ff_promoter_n_RM_12_401_10			3	0.5	2.19E-04	MAFB, LMO2	negative regulation of erythrocyte differentiation [BP]
CG_ff_promoter_n_RM_12_18_7			2	0.5	3.18E-04	GLRX2, ADH5	response to redox state [BP]
CG_ff_promoter_n_RM_12_125_7			2	1.0	3.65E-04	CCBL1	L-phenylalanine:pyruvate aminotransferase activity [MF], L-phenylalanine-oxaloacetate transaminase activity [MF], glutamine-phenylpyruvate transaminase activity [MF], L-glutamine:pyruvate aminotransferase activity [MF]
CG_ff_promoter_n_RM_16_15_3			2	0.5	5.12E-04	CBX4, RBM39, MAML3, U2AF1	nuclear speck [CC]
CG_ff_promoter_n_RM_12_326_7			3	1.0	2.06E-04	ADA, STAT5B	Peyer's patch development [BP]
CG_ff_promoter_n_RM_12_282_7			2	0.5	3.23E-04	C1orf86, STRA13, TOP2B	Fanconi anaemia nuclear complex [CC], resolution of meiotic recombination intermediates [BP]
CG_ff_promoter_n_RM_12_280_7			2	0.5	3.72E-04	SATB2	embryonic pattern specification [BP]
CG_ff_promoter_n_RM_12_328_4			4	1.0	2.13E-05	PLD6, TRPT1	tRNA 2'-phosphotransferase activity [MF], cardiolipin hydrolase activity [MF]
CG_ff_promoter_n_RM_12_347_4			1	0.5	5.84E-04	SLC25A29	acyl carnitine transmembrane transporter activity [MF]
CG_ff_promoter_n_RM_14_5_6			4	0.5	2.52E-04	WNT4	female sex determination [BP], cellular response to transforming growth factor beta stimulus [BP]
CG_ff_promoter_n_RM_12_10_8			3	0.5	6.89E-05	SATB2	histone deacetylase complex [CC]
CG_ff_promoter_n_RM_14_59_4			3	0.5	2.49E-04	LRRC6	diplotene [BP]
CG_ff_promoter_n_RM_14_44_7			3	0.5	2.55E-04	SDF4	zymogen granule exocytosis [BP]
CG_ff_promoter_n_RM_20_1_4			1	0.5	4.56E-04	ZZZ3, PRPF19, ZNF367, TCEA1, CACNG2, GSK3B, POLR2I, LCORL, TOP2A, ZBTB2	DNA binding [MF], ionotropic glutamate receptor binding [MF]
CG_ff_promoter_n_RM_12_358_11			2	1.0	2.36E-04	TCEB2, CTSL2, DPP7, FAF1	ubiquitin protein ligase binding [MF], aminopeptidase activity [MF]
CG_ff_promoter_n_RM_12_305_9			2	0.5	2.63E-04	GNB1, CIB2	photoreceptor inner segment [CC]
CG_ff_promoter_n_RM_12_395_9			3	0.5	2.58E-04	NFKBID, ADAM8	positive regulation of thymocyte apoptotic process [BP]
CG_ff_promoter_n_RM_12_210_15			3	0.5	2.46E-04	ZBED5, TFAP4, ZNF496, CAMTA2, ZNF597, ZNF594, STRA13, GCM2, SETX, HIST1H1A, ZNF721	DNA binding [MF]
CG_ff_promoter_n_RM_14_1_4			3	0.5	4.33E-04	ABCB6, STAT5B, PYCARD	innate immune response [BP], positive regulation of antigen processing and presentation of peptide antigen via MHC class II [BP], cytokine-mediated signaling pathway [BP], positive regulation of activated T cell proliferation [BP], heme-transporting ATPase activity [MF]
CG_ff_promoter_n_RM_12_316_23			4	0.5	2.03E-04	AP5B1, COPE, CDX2, RAB38, OVOL2, MLLT3, BCL11B, SEC31B, TMED1	endosomal transport [BP], regulation of keratinocyte proliferation [BP], protein transport [BP], anterior/posterior pattern specification [BP]
CG_ff_promoter_n_RM_14_84_7			3	0.5	3.46E-04	XBP1	serotonin secretion, neurotransmission [BP], epithelial cell maturation involved in salivary gland development [BP]
CG_ff_promoter_n_RM_16_2_2			1	0.5	4.54E-04	TRIM27	negative regulation of interleukin-2 secretion [BP]
CG_ff_promoter_n_RM_12_146_13			2	0.5	2.68E-04	FEZF2, AMIGO1	axonal fasciculation [BP]
CG_ff_promoter_n_RM_12_168_14			4	0.5	5.08E-04	ROBO1	negative regulation of negative chemotaxis [BP], chemorepulsion involved in postnatal olfactory bulb interneuron migration [BP], positive regulation of axonogenesis [BP]
CG_ff_promoter_n_RM_16_6_2			1	0.5	1.00E-04	CXXC1	unmethylated CpG binding [MF]
CG_ff_promoter_n_RM_14_78_4			2	0.5	3.26E-04	MED20, SALL1, SATB1, ABO, POLRMT	glycoprotein-fucosylgalactoside alpha-N-acetylgalactosaminyltransferase activity [MF], CD4-positive, alpha-beta T cell differentiation [BP], DNA-directed RNA polymerase activity [MF], inductive cell-cell signaling [BP], fucosylgalactoside 3-alpha-galactosyltransferase activity [MF]
CG_ff_promoter_n_RM_14_42_2			5	0.5	3.37E-04	CD59	negative regulation of activation of membrane attack complex [BP]
CG_ff_promoter_n_RM_12_197_13			2	0.5	2.11E-04	RBBP7, CTBP1	transcriptional repressor complex [CC], cellular heat acclimation [BP], regulation of transcription by chromatin organization [BP]
CG_ff_promoter_n_RM_14_86_2			2	0.5	3.28E-04	CDK5, ITGB7, ROCK2	acetylcholine receptor activator activity [MF], cell-matrix adhesion [BP], positive regulation of centrosome duplication [BP]
CG_ff_promoter_n_RM_12_284_9			2	0.5	3.17E-04	FGF8, SLC38A7	cell migration involved in mesendoderm migration [BP], L-leucine transmembrane transporter activity [MF], L-methionine transmembrane transporter activity [MF]
CG_ff_promoter_n_RM_12_346_11			1	0.5	1.49E-04	MTOR, FBP1, GALK1, GNA14	regulation of carbohydrate utilization [BP], mTOR-FKBP12-rapamycin complex [CC], signal transduction [BP], carbohydrate metabolic process [BP], monosaccharide binding [MF]
CG_ff_promoter_n_RM_12_138_10			2	1.0	3.72E-05	HLCS	biotin-protein ligase activity [MF], biotin-[methylcrotonoyl-CoA-carboxylase] ligase activity [MF], biotin-[methylmalonyl-CoA-carboxytransferase] ligase activity [MF], protein biotinylation [BP], biotin-[acetyl-CoA-carboxylase] ligase activity [MF], biotin-[propionyl-CoA-carboxylase (ATP-hydrolyzing)] ligase activity [MF], histone biotinylation [BP]
CG_ff_promoter_n_RM_12_406_6			2	1.0	2.21E-04	CYGB, UBA7, CYP17A1	steroid 17-alpha-monooxygenase activity [MF], ISG15 activating enzyme activity [MF], response to acetate [BP], oxygen binding [MF]
CG_ff_promoter_n_RM_14_75_4			3	0.5	3.29E-04	PSIP1, CYP39A1, CAMK2B, POU4F1, GCNT4	steroid 7-alpha-hydroxylase activity [MF], inhibitory G-protein coupled receptor phosphorylation [BP], inter-male aggressive behavior [BP], proprioception involved in equilibrioception [BP], supercoiled DNA binding [MF], neuromuscular process controlling balance [BP], 24-hydroxycholesterol 7alpha-hydroxylase activity [MF]
CG_ff_promoter_n_RM_12_50_10			3	0.5	4.56E-05	BMP4, JAG2	BMP signaling pathway involved in renal system segmentation [BP], bud dilation involved in lung branching [BP], inner ear receptor cell differentiation [BP], odontogenesis of dentin-containing tooth [BP], neuron fate commitment [BP], specification of ureteric bud anterior/posterior symmetry by BMP signaling pathway [BP], odontogenesis [BP], negative regulation of branch elongation involved in ureteric bud branching by BMP signaling pathway [BP], negative regulation of mesenchymal cell proliferation involved in ureter development [BP], negative regulation of metanephric comma-shaped body morphogenesis [BP], negative regulation of cell proliferation involved in heart morphogenesis [BP], negative regulation of metanephric S-shaped body morphogenesis [BP], pulmonary artery endothelial tube morphogenesis [BP], positive regulation of branching involved in lung morphogenesis [BP], negative regulation of glomerulus development [BP], BMP signaling pathway involved in nephric duct formation [BP], intermediate mesodermal cell differentiation [BP], BMP signaling pathway involved in ureter morphogenesis [BP], ureter epithelial cell differentiation [BP], positive regulation of cardiac muscle fiber development [BP]
CG_ff_promoter_n_RM_12_208_13			3	0.5	3.04E-04	SIAH1, OTX2, SPON2	axon guidance [BP]
CG_ff_promoter_n_RM_14_53_11			4	1.0	8.45E-06	H2AFY, HVCN1	Barr body [CC], voltage-gated proton channel activity [MF]
CG_ff_promoter_n_RM_14_73_6			3	0.5	2.40E-04	WNT7B, ERF	embryonic placenta morphogenesis [BP], establishment or maintenance of polarity of embryonic epithelium [BP], chorio-allantoic fusion [BP], outer medullary collecting duct development [BP]
CG_ff_promoter_n_RM_14_100_6			1	0.5	1.95E-04	PNKP	polynucleotide 3'-phosphatase activity [MF], nucleotide phosphorylation [BP], ATP-dependent polydeoxyribonucleotide 5'-hydroxyl-kinase activity [MF]
CG_ff_promoter_n_RM_12_58_11			3	0.5	3.83E-04	USP7, FOXL2	regulation of sequence-specific DNA binding transcription factor activity [BP]
CG_ff_promoter_n_RM_12_228_20			3	0.5	3.50E-04	RTKN, CDK6, DGKI	cyclin-dependent protein kinase holoenzyme complex [CC], GTPase inhibitor activity [MF], Ras GTPase binding [MF]
CG_ff_promoter_n_RM_12_184_13			2	0.5	2.54E-04	FAM57B, TMEM50B, PDE2A, SLC27A5, BCL2, SFRP2	endoplasmic reticulum [CC], negative regulation of cell growth [BP]
CG_ff_promoter_n_RM_12_166_6			2	0.5	2.85E-04	EPOR	erythropoietin receptor activity [MF]
CG_ff_promoter_n_RM_14_30_9			3	0.5	4.90E-04	SMEK1, ASCL2, TWIST1, FOXL2, GAS1, DUSP4, PPP2CA	protein dephosphorylation [BP], embryonic digit morphogenesis [BP], inactivation of MAPK activity [BP], E-box binding [MF], female somatic sex determination [BP], negative regulation of transcription, DNA-dependent [BP], menstruation [BP], eye morphogenesis [BP], embryonic cranial skeleton morphogenesis [BP], outer ear morphogenesis [BP], embryonic eye morphogenesis [BP], positive regulation of endocardial cushion to mesenchymal transition involved in heart valve formation [BP], cell proliferation involved in heart valve development [BP]
CG_ff_promoter_n_RM_12_321_19			3	0.5	3.23E-04	DUSP16, SLC23A1	MAPK phosphatase export from nucleus, leptomycin B sensitive [BP], MAPK export from nucleus [BP], dehydroascorbic acid transport [BP]
CG_ff_promoter_n_RM_12_141_9			1	0.5	9.33E-06	ALDH3A1, KCNJ8	3-chloroallyl aldehyde dehydrogenase activity [MF], potassium ion import [BP], aldehyde dehydrogenase [NAD(P)+] activity [MF], ATP-sensitive potassium channel complex [CC], ATP-activated inward rectifier potassium channel activity [MF]
CG_ff_promoter_n_RM_14_82_6			4	0.5	3.97E-04	SESN3, CUL3, DNAJC1, MLL3, TAF11, RBMS1, WASL, PDE2A, ATXN7L3, ANKRD11, GTF2E2, LHX5, SBF1, PRPF19, COMMD6, CSRNP1, PERP, RANBP9, ZNF768, PJA2, PKM, CUL2, TOP2A, EDF1, ZBTB2, ZBTB7A, ZZZ3, SP3, ZNF367, TCEA1, AGAP2, BARX1, EBF3, SATB2, ZER1, CENPV, EVX2, POLR2I, SOS2, KIAA2022, LIN54, TBL1XR1, GLRA1, AKT2, GSK3B, PDE4DIP, REV3L, NKX3-2, PIP4K2B, BCL6, LCORL, EBF2, KCTD1	DNA binding [MF], transcription elongation from RNA polymerase II promoter [BP], protein kinase A catalytic subunit binding [MF], regulation of transcription, DNA-dependent [BP], Cul2-RING ubiquitin ligase complex [CC], transcription, DNA-dependent [BP], intracellular membrane-bounded organelle [CC], embryonic cleavage [BP], nucleus [CC]
CG_ff_promoter_n_RM_16_4_3			1	0.5	1.62E-04	DERL1, MAPK3	negative regulation of apolipoprotein binding [BP], late endosome [CC]
CG_ff_promoter_n_RM_12_145_4			2	0.5	1.34E-04	CELSR1, SHANK1, GPCPD1, DAB1	protein localization involved in establishment of planar polarity [BP], determination of affect [BP], somatostatin receptor binding [MF], habituation [BP], cell-cell adhesion involved in neuronal-glial interactions involved in cerebral cortex radial glia guided migration [BP], glycerophosphocholine phosphodiesterase activity [MF]
CG_ff_promoter_n_RM_12_164_14			2	0.5	3.35E-04	BCL11B, CSNK1E, HOXA3, PPP2R5E, CITED2, GJB6, PRICKLE1	cranial nerve morphogenesis [BP], positive regulation of proteasomal ubiquitin-dependent protein catabolic process [BP], thymus development [BP], intracellular membrane-bounded organelle [CC]
CG_ff_promoter_n_RM_12_272_10			4	0.5	3.19E-04	CD14, SRXN1, CDK5, PYCARD	positive regulation of antigen processing and presentation of peptide antigen via MHC class II [BP], sulfiredoxin activity [MF], positive regulation of tumor necrosis factor production [BP], positive regulation of cytokine secretion [BP], activation of innate immune response [BP], acetylcholine receptor activator activity [MF]
CG_ff_promoter_n_RM_12_182_9			3	0.5	2.98E-04	PSMB5, PPP6C, CUL2, LATS2	G1/S transition of mitotic cell cycle [BP]
CG_ff_promoter_n_RM_14_88_5			3	0.5	5.33E-04	GNG7, HOXA5, GNB1, SLC30A2, ALG2	protein glycosylation in endoplasmic reticulum [BP], positive regulation of sequestering of zinc ion [BP], GDP-Man:Man1GlcNAc2-PP-Dol alpha-1,3-mannosyltransferase activity [MF], cell-cell signaling involved in mammary gland development [BP], heterotrimeric G-protein complex [CC], cellular response to glucagon stimulus [BP]
CG_ff_promoter_n_RM_12_149_13			2	0.5	3.40E-04	FGF10, HOXB3	thyroid gland development [BP]
CG_ff_promoter_n_RM_14_32_2			2	0.5	3.63E-04	PLA2R1	negative regulation of arachidonic acid secretion [BP], negative regulation of phospholipase A2 activity [BP]
CG_ff_promoter_n_RM_12_140_12			3	1.0	2.55E-04	LRRC6, MAFB, SEPT12, UNC5C	rhombomere 6 development [BP], netrin receptor activity [MF], sperm annulus [CC], diplotene [BP]
CG_ff_promoter_n_RM_12_160_7			1	0.5	3.39E-04	AGAP2, UQCRB, HIST1H2BJ, HIST1H2BL	mitochondrial respiratory chain [CC], negative regulation of protein catabolic process [BP], nucleosome [CC]
CG_ff_promoter_n_RM_12_98_7			3	1.0	1.83E-04	NEBL, PAX8, MST1R	regulation of thyroid-stimulating hormone secretion [BP], cardiac muscle thin filament assembly [BP], stress fiber [CC]
CG_ff_promoter_n_RM_12_295_19			4	0.5	2.70E-04	BCAR1	regulation of apoptotic process [BP]
CG_ff_promoter_n_RM_14_13_4			2	0.5	2.05E-04	TJP1, LATS2	hippo signaling cascade [BP]
CG_ff_promoter_n_RM_12_370_16			3	0.5	2.01E-04	AHCTF1, RFC4, GATM, LSG1, DUSP7, XPO1	glycine amidinotransferase activity [MF], nucleoplasm [CC], Cajal body [CC]
CG_ff_promoter_n_RM_12_252_9			4	0.5	3.30E-04	STX5, BET1L	SNAP receptor activity [MF]
CG_ff_promoter_n_RM_20_15_1			1	0.5	2.17E-06	LRPAP1	rough endoplasmic reticulum lumen [CC], low-density lipoprotein particle receptor binding [MF], asialoglycoprotein receptor activity [MF], lipase binding [MF], negative regulation of beta-amyloid clearance [BP], extracellular negative regulation of signal transduction [BP], receptor antagonist activity [MF], very-low-density lipoprotein particle receptor binding [MF], negative regulation of very-low-density lipoprotein particle clearance [BP]
CG_ff_promoter_n_RM_14_15_3			3	0.5	3.28E-04	DLG4, CDC42EP3, SLC7A10, TBX3, CTBP1, TAX1BP3	regulation of transcription by chromatin organization [BP], atrioventricular bundle cell differentiation [BP], P2Y1 nucleotide receptor binding [MF], sinoatrial node cell development [BP], protein C-terminus binding [MF], D-alanine transport [BP], cytoskeletal regulatory protein binding [MF]
CG_ff_promoter_n_RM_12_91_8			2	0.5	2.46E-04	PSRC1, HOOK2	microtubule binding [MF]
CG_ff_promoter_n_RM_12_207_14			3	0.5	3.59E-04	TRPT1	tRNA 2'-phosphotransferase activity [MF]
CG_ff_promoter_n_RM_12_332_10			3	0.5	2.87E-04	RAB27A, LOXL2, CHD1	methylated histone residue binding [MF], cytotoxic T cell degranulation [BP]
CG_ff_promoter_n_RM_12_72_8			1	0.5	2.79E-04	MYBBP1A	NLS-dependent protein nuclear import complex [CC]
CG_ff_promoter_n_RM_20_17_2			2	1.0	7.46E-04	HIST3H2A, HIST1H1B, H2AFX	nucleosome assembly [BP], nucleosome [CC], nuclear chromatin [CC]
CG_ff_promoter_n_RM_12_100_8			2	1.0	1.63E-04	NTRK3, SLC16A8	lactate transmembrane transport [BP], modulation by virus of host transcription [BP], lactate transport [BP], positive regulation of axon extension involved in regeneration [BP]
CG_ff_promoter_n_RM_12_78_9			1	0.5	2.56E-05	FASN, F3	3-hydroxypalmitoyl-[acyl-carrier-protein] dehydratase activity [MF], oleoyl-[acyl-carrier-protein] hydrolase activity [MF], myristoyl-[acyl-carrier-protein] hydrolase activity [MF], [acyl-carrier-protein] S-malonyltransferase activity [MF], enoyl-[acyl-carrier-protein] reductase (NADPH, B-specific) activity [MF], [acyl-carrier-protein] S-acetyltransferase activity [MF], 3-oxoacyl-[acyl-carrier-protein] synthase activity [MF], palmitoyl-[acyl-carrier-protein] hydrolase activity [MF], activation of blood coagulation via clotting cascade [BP], 3-hydroxyoctanoyl-[acyl-carrier-protein] dehydratase activity [MF], 3-oxoacyl-[acyl-carrier-protein] reductase (NADPH) activity [MF], positive regulation of platelet-derived growth factor receptor signaling pathway [BP]
CG_ff_promoter_n_RM_12_380_21			3	0.5	2.78E-04	STK10	polo kinase kinase activity [MF]
CG_ff_promoter_n_RM_12_334_12			4	0.5	2.96E-04	RUNX1	regulatory region DNA binding [MF]
CG_ff_promoter_n_RM_14_17_5			3	0.5	4.39E-04	DLG4, NOTCH1, KCNMA1, NOP14, TOB1, ESR2	negative regulation of BMP signaling pathway [BP], Noc4p-Nop14p complex [CC], negative regulation of osteoblast differentiation [BP], inflammatory response to antigenic stimulus [BP], prostate gland epithelium morphogenesis [BP], auditory receptor cell differentiation [BP], P2Y1 nucleotide receptor binding [MF]
CG_ff_promoter_n_RM_14_19_4			2	1.0	1.79E-04	TH	cellular response to manganese ion [BP], terpene metabolic process [BP], epinephrine biosynthetic process [BP], tyrosine 3-monooxygenase activity [MF], dopamine biosynthetic process from tyrosine [BP], synaptic vesicle amine transport [BP], phytoalexin metabolic process [BP], multicellular organismal aging [BP]
CG_ff_promoter_n_RM_12_106_2			2	0.5	1.99E-04	LMNB2, UBE2N, SUN2	nuclear envelope [CC], nuclear inner membrane [CC], nuclear migration along microfilament [BP], UBC13-UEV1A complex [CC], UBC13-MMS2 complex [CC]
CG_ff_promoter_n_RM_20_11_2			2	1.0	4.39E-05	PSG9, PSG6, PSG5, PSG2, PSG3, PSG1, PSG11	female pregnancy [BP], extracellular region [CC]
CG_ff_promoter_n_RM_12_390_14			4	0.5	1.93E-04	NME3, ALX3	apoptotic process [BP], regulation of apoptotic process [BP]
CG_ff_promoter_n_RM_12_392_11			2	0.5	2.29E-04	POU3F1, LGI4	myelination in peripheral nervous system [BP], axon ensheathment [BP]
CG_ff_promoter_n_RM_12_254_4			3	0.5	3.08E-04	SMARCC1, DPF3	nBAF complex [CC]
CG_ff_promoter_n_RM_12_371_9			4	0.5	1.98E-04	PITPNA	stearic acid binding [MF]
CG_ff_promoter_n_RM_14_85_16			4	0.5	4.12E-04	MLL3, TAF11, GTF2E2, PRPF19, ZER1, CSRNP1, PJA2, CUL2, TOP2A, ZBTB2, ZBTB7A, ZZZ3, ZNF367, TCEA1, EBF3, EVX2, POLR2I, SOS2, DNAJC1, GSK3B, LIN54, LCORL, CUL3	protein kinase A catalytic subunit binding [MF], DNA binding [MF], embryonic cleavage [BP], Cul2-RING ubiquitin ligase complex [CC]
CG_ff_promoter_n_RM_12_70_6			2	0.5	2.22E-04	NODAL, DPT, MKX, CPXM1	tendon sheath development [BP], transforming growth factor beta receptor signaling pathway involved in primitive streak formation [BP], epiblast cell-extraembryonic ectoderm cell signaling involved in anterior/posterior axis specification [BP], axial mesodermal cell fate specification [BP], cell adhesion [BP], collagen fibril organization [BP], inhibition of neuroepithelial cell differentiation [BP]
CG_ff_promoter_n_RM_12_74_10			2	1.0	7.59E-05	KCNA2, NRARP, SLC12A4	potassium:chloride symporter activity [MF], potassium ion transport [BP], optic nerve structural organization [BP], blood vessel endothelial cell proliferation involved in sprouting angiogenesis [BP]
CG_ff_promoter_n_RM_12_237_8			4	0.5	3.25E-04	FOXP1, JAK3, PAX6, CREG1, HES2	regulation of cardiac muscle cell proliferation [BP], transcription factor binding [MF], ventral spinal cord development [BP], STAT protein import into nucleus [BP], tyrosine phosphorylation of STAT protein [BP]
CG_ff_promoter_n_RM_12_387_6			2	0.5	3.17E-04	ZC3HAV1, ART5	NAD+ ADP-ribosyltransferase activity [MF]
CG_ff_promoter_n_RM_14_2_6			4	1.0	3.29E-04	NKX3-1, KCNJ11	response to testosterone stimulus [BP]
CG_ff_promoter_n_RM_18_9_1			1	0.5	5.95E-05	ALDH9A1	4-trimethylammoniobutyraldehyde dehydrogenase activity [MF], 3-chloroallyl aldehyde dehydrogenase activity [MF], aminobutyraldehyde dehydrogenase activity [MF], carnitine biosynthetic process [BP], 1-pyrroline dehydrogenase activity [MF]
CG_ff_promoter_n_RM_12_333_11			4	0.5	2.78E-04	PITPNA, CHDH	choline dehydrogenase activity [MF], stearic acid binding [MF]
CG_ff_promoter_n_RM_12_385_7			1	0.5	3.43E-04	JUP	gamma-catenin-TCF7L2 complex [CC], structural constituent of cell wall [MF]
CG_ff_promoter_n_RM_14_45_9			3	0.5	1.54E-04	ADAM8, SH3PXD2A	podosome [CC]
CG_ff_promoter_n_RM_18_4_1			1	0.5	1.58E-04	HPSE2, ART5, ACHE	negative regulation of synaptic transmission, cholinergic [BP], neurotransmitter receptor biosynthetic process [BP], NAD+ nucleosidase activity [MF], cholinesterase activity [MF], heparanase activity [MF], acetylcholinesterase activity [MF], acetylcholine catabolic process [BP], acetylcholine catabolic process in synaptic cleft [BP]
CG_ff_promoter_n_RM_16_3_2			1	0.5	6.35E-05	AMICA1, SERPINA10, KCNMB1	blood coagulation [BP]
CG_ff_promoter_n_RM_12_193_11			2	0.5	2.68E-04	FZD8, AXIN1, SLC4A11	canonical Wnt receptor signaling pathway involved in neural plate anterior/posterior pattern formation [BP], phosphoenolpyruvate-dependent sugar phosphotransferase system [BP], positive regulation of JUN kinase activity [BP], Wnt receptor signaling pathway involved in forebrain neuron fate commitment [BP], borate transmembrane transporter activity [MF], borate transport [BP], borate transmembrane transport [BP]
CG_ff_promoter_n_RM_12_225_19			2	0.5	2.97E-04	KCNH2, KCNB1	delayed rectifier potassium channel activity [MF]
CG_ff_promoter_n_RM_18_2_3			3	1.0	4.92E-04	CBX4, BCL11A, ITPK1	inositol tetrakisphosphate 1-kinase activity [MF], inositol-1,3,4-trisphosphate 6-kinase activity [MF], protein sumoylation [BP], inositol-1,3,4-trisphosphate 5-kinase activity [MF]
CG_ff_promoter_n_RM_14_20_5			1	0.5	5.96E-04	CBX8	nuclear chromatin [CC]
CG_ff_promoter_n_RM_12_235_6			3	0.5	1.42E-04	EPHA2, GART	notochord cell development [BP], phosphoribosylformylglycinamidine cyclo-ligase activity [MF], phosphoribosylglycinamide formyltransferase activity [MF], phosphoribosylamine-glycine ligase activity [MF]
CG_ff_promoter_n_RM_12_396_15			2	0.5	2.43E-04	PHB	cellular response to interleukin-6 [BP]
CG_ff_promoter_n_RM_16_7_3			1	0.5	1.37E-05	PSG5, PSG11, PSG9, PSG6	female pregnancy [BP], extracellular region [CC]
CG_ff_promoter_n_RM_16_1_2			1	0.5	1.17E-04	IGF1, FHIT, BDNF	satellite cell maintenance involved in skeletal muscle regeneration [BP], response to anesthetic [BP], glycolate metabolic process [BP], positive regulation of myoblast proliferation [BP], myotube cell development [BP], insulin-like growth factor binding protein complex [CC], prostate gland stromal morphogenesis [BP], Type I pneumocyte differentiation [BP], inner ear development [BP], response to fluoxetine [BP], growth factor activity [MF], bis(5'-adenosyl)-triphosphatase activity [MF], neurotrophin TRKB receptor binding [MF]
CG_ff_promoter_n_RM_14_87_2			3	0.5	4.97E-04	NUMBL, TLR9	positive regulation of interleukin-18 production [BP], neuroblast division in subventricular zone [BP]
CG_ff_promoter_n_RM_14_71_4			1	0.5	6.26E-04	TWIST1, NGF, POLG, PAFAH1B3, MLXIPL	lipid metabolic process [BP], positive regulation of nerve growth factor receptor signaling pathway [BP], gamma DNA polymerase complex [CC], negative regulation of peroxisome proliferator activated receptor signaling pathway [BP], negative regulation of histone phosphorylation [BP], carbohydrate response element binding [MF], negative regulation of oxidative phosphorylation uncoupler activity [BP], negative regulation of oxidative phosphorylation [BP], nerve growth factor receptor binding [MF], glucose mediated signaling pathway [BP], positive regulation of endocardial cushion to mesenchymal transition involved in heart valve formation [BP], cell proliferation involved in heart valve development [BP], protein heterodimerization activity [MF]
CG_ff_promoter_n_RM_12_355_4			1	0.5	4.49E-05	TBX5	bundle of His development [BP], cardiac left ventricle formation [BP], negative regulation of cardiac muscle cell proliferation [BP], positive regulation of cardioblast differentiation [BP], cell migration involved in coronary vasculogenesis [BP]
CG_ff_promoter_n_RM_16_17_3			2	0.5	5.30E-04	HDAC5, HNF1B, NID1, BCL6, LCORL, BCL2, ZBTB2	B cell activation [BP], DNA binding [MF], B cell differentiation [BP], positive regulation of B cell proliferation [BP], negative regulation of mitotic cell cycle [BP], cell-matrix adhesion [BP]
CG_ff_promoter_n_RM_12_167_7			2	0.5	1.18E-04	SLC19A1, MTHFS	folic acid binding [MF]
CG_ff_promoter_n_RM_12_232_11			2	0.5	3.11E-04	GLIS1, MNX1, ZNF367, NRL, NACC2	transcription from RNA polymerase II promoter [BP], regulation of transcription from RNA polymerase II promoter [BP]
CG_ff_promoter_n_RM_12_227_13			1	0.5	3.69E-04	TFF3	apical lamina of hyaline layer [CC]
CG_ff_promoter_n_RM_12_181_9			3	0.5	2.85E-04	EIF5A2	polyamine homeostasis [BP]
CG_ff_promoter_n_RM_12_381_6			2	0.5	3.57E-04	SLC6A3	response to nicotine [BP]
CG_ff_promoter_n_RM_12_165_8			2	0.5	3.73E-04	ATE1, WNK3	positive regulation of rubidium ion transport [BP], protein arginylation [BP], positive regulation of rubidium ion transmembrane transporter activity [BP], arginyltransferase activity [MF]
CG_ff_promoter_n_RM_14_41_8			5	0.5	3.20E-04	SSBP3, PLA2R1	prechordal plate formation [BP], negative regulation of arachidonic acid secretion [BP], midbrain-hindbrain boundary initiation [BP], negative regulation of phospholipase A2 activity [BP]
CG_ff_promoter_n_RM_12_92_20			3	1.0	4.77E-05	HMGCL	hydroxymethylglutaryl-CoA lyase activity [MF]
CG_ff_promoter_n_RM_12_111_10			2	1.0	3.35E-04	HYI	hydroxypyruvate isomerase activity [MF]
CG_ff_promoter_n_RM_14_48_11			3	0.5	4.20E-04	ARHGEF11, SMARCC1, STRN3, HSPG2, DKK3, NPHP3, GSK3B, HOXA7, CITED2, ALX4, ROR2, SMARCC2	embryonic skeletal system morphogenesis [BP], npBAF complex [CC], anatomical structure morphogenesis [BP], adrenal gland development [BP], positive regulation of transcription, DNA-dependent [BP], negative regulation of canonical Wnt receptor signaling pathway [BP], organ morphogenesis [BP], SWI/SNF complex [CC], negative regulation of transcription, DNA-dependent [BP], nBAF complex [CC], nucleosome disassembly [BP], negative regulation of gene expression [BP], canonical Wnt receptor signaling pathway [BP], positive regulation of gene expression [BP], skeletal system development [BP]
CG_ff_promoter_n_RM_12_353_8			1	0.5	2.19E-04	GRM4, CFL1, ARRB1, SORT1, KDM5B, AVP	positive regulation of peptidyl-serine phosphorylation [BP], V1B vasopressin receptor binding [MF], protein phosphorylation [BP], cysteine-type endopeptidase inhibitor activity involved in apoptotic process [MF], coated pit [CC], neurotensin receptor activity, non-G-protein coupled [MF], histone H3-K4 demethylation, trimethyl-H3-K4-specific [BP], histone demethylase activity (H3-trimethyl-K4 specific) [MF], presynaptic active zone membrane [CC]
CG_ff_promoter_n_RM_12_275_8			1	0.5	1.51E-05	ABCA2, IL12RB1	interleukin-23 receptor complex [CC], interleukin-23-mediated signaling pathway [BP], interleukin-23 binding [MF], interleukin-12 receptor complex [CC], regulation of intracellular cholesterol transport [BP], interleukin-12 receptor activity [MF], interleukin-23 receptor activity [MF]
CG_ff_promoter_n_RM_12_335_9			2	0.5	3.45E-04	SLC26A6	formate transmembrane transporter activity [MF]
CG_ff_promoter_n_RM_14_83_4			3	0.5	2.13E-04	CRMP1	microtubule organizing center [CC]
CG_ff_promoter_n_RM_12_259_9			2	0.5	1.52E-04	EZH2, AKT1, WNK3	positive regulation of sodium ion transport [BP], positive regulation of establishment of protein localization to plasma membrane [BP], pronucleus [CC]
CG_ff_promoter_n_RM_14_63_2			1	0.5	4.02E-05	NACC2, SLC25A11, MLXIPL	negative regulation of G1/S transition of mitotic cell cycle by negative regulation of transcription from RNA polymerase II promoter [BP], carbohydrate response element binding [MF], negative regulation of oxidative phosphorylation [BP], glucose mediated signaling pathway [BP], alpha-ketoglutarate transport [BP], oxoglutarate:malate antiporter activity [MF]
CG_ff_promoter_n_RM_12_350_9			3	0.5	2.77E-04	NDUFA10, GSPT1	phosphotransferase activity, alcohol group as acceptor [MF], intracellular [CC]
CG_ff_promoter_n_RM_12_308_14			3	0.5	3.40E-04	RNASEH1	nucleic acid binding [MF]
CG_ff_promoter_n_RM_12_239_22			2	0.5	3.26E-04	TONSL, FZD5, NDN, SALL1, KIF1A, GIP, TCP1, KIF21B, TPPP3, FOXL2, GDNF, HOXA1, CXCR4, NDRG1, STRA13, SEMA6A, NINL, FGFR1, TXN	response to selenium ion [BP], axonogenesis [BP], neuron projection development [BP], myelin maintenance [BP], microtubule [CC], neuron migration [BP], pattern specification process [BP], outer ear morphogenesis [BP], replication fork processing [BP]
CG_ff_promoter_n_RM_12_142_7			1	0.5	1.16E-05	MGAT1	alpha-1,3-mannosylglycoprotein 2-beta-N-acetylglucosaminyltransferase activity [MF], UDP-N-acetylglucosamine catabolic process [BP]
CG_ff_promoter_n_RM_12_211_9			3	0.5	3.33E-04	HSPA5, RRP8	cellular response to glucose starvation [BP]
CG_ff_promoter_n_RM_14_65_4			2	0.5	3.52E-04	ADRA2B, SPRY2	activation of MAPK activity by adrenergic receptor signaling pathway [BP], positive regulation of protein serine/threonine kinase activity [BP], alpha2-adrenergic receptor activity [MF], epidermal growth factor receptor signaling pathway [BP], negative regulation of nerve growth factor receptor signaling pathway [BP], regulation of vascular smooth muscle contraction [BP], lung growth [BP], epidermal growth factor-activated receptor transactivation by G-protein coupled receptor signaling pathway [BP]
CG_ff_promoter_n_RM_16_9_2			1	0.5	4.64E-04	YARS2	tyrosine binding [MF], tyrosine-tRNA ligase activity [MF], mitochondrial tyrosyl-tRNA aminoacylation [BP]
CG_ff_promoter_n_RM_12_244_9			2	0.5	1.85E-04	NUDT18	dGDP catabolic process [BP], GDP catabolic process [BP], dADP catabolic process [BP]
CG_ff_promoter_n_RM_12_102_14			2	0.5	1.07E-04	SLC7A10, ACSBG1, NUDT18	GDP catabolic process [BP], 8-oxo-dGDP phosphatase activity [MF], 8-oxo-GDP phosphatase activity [MF], dADP catabolic process [BP], dGDP catabolic process [BP], ovarian follicle atresia [BP], 8-hydroxy-dADP phosphatase activity [MF], D-alanine transport [BP]
CG_ff_promoter_n_RM_12_323_3			4	1.0	4.16E-04	PCDH1, DLL1, FOXA1	neuron fate specification [BP], cell-cell signaling [BP]
CG_ff_promoter_n_RM_12_270_11			4	0.5	2.62E-04	FZD5, TWIST1, DEAF1, GAS1, NKX3-2, TP53BP2, RNF152, BCL7C, IL2RA	programmed cell death [BP], outer ear morphogenesis [BP], apoptotic process [BP], embryonic skeletal system development [BP]
CG_ff_promoter_n_RM_12_251_9			3	0.5	2.47E-04	TAF1A, HAND2, ERCC2, ZFHX2, LDB1, SATB2, HOXA1, IRX4, PYGO1, MYH10	transcription initiation from RNA polymerase I promoter [BP], positive regulation of DNA binding [BP], adult heart development [BP], termination of RNA polymerase I transcription [BP], sequence-specific DNA binding [MF], transcription elongation from RNA polymerase I promoter [BP], positive regulation of transcription from RNA polymerase II promoter [BP], cerebellar Purkinje cell layer development [BP], transcription factor complex [CC]
CG_ff_promoter_n_RM_12_103_7			2	0.5	1.90E-05	ECE1, ODC1	substance P catabolic process [BP], ornithine decarboxylase activity [MF], Weibel-Palade body [CC], calcitonin catabolic process [BP], endothelin maturation [BP], putrescine biosynthetic process from ornithine [BP], intrinsic to endosome membrane [CC]
CG_ff_promoter_n_RM_12_404_14			2	0.5	2.72E-04	GSK3A, OXER1	5-hydroxy-6E,8Z,11Z,14Z-icosatetraenoic acid binding [MF], negative regulation of UDP-glucose catabolic process [BP], 5(S)-hydroxyperoxy-6E,8Z,11Z,14Z-icosatetraenoic acid binding [MF], 5-oxo-6E,8Z,11Z,14Z-icosatetraenoic acid binding [MF]
CG_ff_promoter_n_RM_12_253_4			1	0.5	1.80E-04	MEFV, ANKLE2, GBGT1, SNX5, HYAL2	macropinocytic cup [CC], globoside alpha-N-acetylgalactosaminyltransferase activity [MF], mitotic nuclear envelope reassembly [BP], negative regulation of macrophage inflammatory protein 1 alpha production [BP], receptor signaling protein tyrosine kinase inhibitor activity [MF]
CG_ff_promoter_n_RM_14_67_5			2	0.5	1.86E-04	ANKLE2	mitotic nuclear envelope reassembly [BP]
CG_ff_promoter_n_RM_12_342_10			2	0.5	3.35E-04	HMGB1, MAN1A1, SEC24D, ST8SIA6, PYCARD	myeloid dendritic cell activation [BP], protein N-linked glycosylation via asparagine [BP], positive regulation of cysteine-type endopeptidase activity [BP], positive regulation of cysteine-type endopeptidase activity involved in apoptotic process [BP], glycoprotein metabolic process [BP]
CG_ff_promoter_n_RM_12_255_6			3	0.5	4.64E-04	TLL2, ARL3, SIX1, ADAMTS8, MSC, WT1	regulation of organ formation [BP], negative regulation of metanephric glomerular mesangial cell proliferation [BP], kidney development [BP], low affinity phosphate transmembrane transporter activity [MF], metanephric mesenchyme development [BP], diaphragm development [BP], multicellular organismal development [BP]
CG_ff_promoter_n_RM_12_162_10			2	1.0	3.12E-04	SLC7A10	D-alanine transport [BP]
CG_ff_promoter_n_RM_14_46_7			5	0.5	2.04E-04	RAB3A, AXIN2	maintenance of presynaptic active zone structure [BP], mRNA stabilization [BP], regulation of chondrocyte development [BP]
CG_ff_promoter_n_RM_12_257_9			2	1.0	3.96E-04	PGAP1	myo-inositol transport [BP]
CG_ff_promoter_n_RM_20_18_1			1	0.5	1.74E-04	RNH1	ribonuclease inhibitor activity [MF]
CG_ff_promoter_n_RM_12_271_6			4	0.5	3.25E-04	AP5B1, UFSP1	UFM1 hydrolase activity [MF], AP-type membrane coat adaptor complex [CC]
CG_ff_promoter_n_RM_20_12_1			1	0.5	1.78E-04	CYP3A4	albendazole monooxygenase activity [MF], taurochenodeoxycholate 6alpha-hydroxylase activity [MF], quinine 3-monooxygenase activity [MF], testosterone 6-beta-hydroxylase activity [MF]
CG_ff_promoter_n_RM_12_283_12			2	0.5	4.57E-04	SOCS1, NLRP10, PRKCQ	negative regulation of insulin receptor signaling pathway [BP], positive regulation of T-helper 17 type immune response [BP]
CG_ff_promoter_n_RM_14_68_2			2	0.5	1.96E-04	PODXL	regulation of microvillus assembly [BP]
CG_ff_promoter_n_RM_12_281_16			2	0.5	2.71E-04	RPA2, LIG4	nucleotide-excision repair, DNA gap filling [BP]
CG_ff_promoter_n_RM_20_10_2			2	1.0	7.79E-04	HIST3H2A, HIST1H1B, H2AFX	nucleosome assembly [BP], nucleosome [CC], nuclear chromatin [CC]
CG_ff_promoter_n_RM_12_39_11			2	0.5	3.49E-04	NEUROD2, BSX, BTG1, KLF14, HRAS, SOHLH1, TESC, REXO1, ERF, ID3, EBF3, NACC2, CASP9, MPHOSPH6, ZNF514, PPM1G	nucleus [CC]
CG_ff_promoter_n_RM_12_88_10			2	1.0	1.58E-04	ACER1	dihydroceramidase activity [MF]
CG_ff_promoter_n_RM_12_230_9			2	0.5	3.36E-04	KIF16B, GNB1, ECE1, COL12A1, NKX2-5, TRMT112	proepicardium development [BP], positive regulation of voltage-gated calcium channel activity [BP], substance P catabolic process [BP], endothelin maturation [BP], collagen type XII [CC], pharyngeal system development [BP], calcitonin catabolic process [BP], regulation of receptor recycling [BP], peptidyl-glutamine methylation [BP], cardiac muscle cell apoptotic process [BP], Purkinje myocyte differentiation [BP], atrioventricular node cell fate commitment [BP], intrinsic to endosome membrane [CC]
CG_ff_promoter_n_RM_20_5_2			1	0.5	1.10E-04	MARCH1	antigen processing and presentation of peptide antigen via MHC class II [BP]
CG_ff_promoter_n_RM_12_133_17			1	0.5	6.67E-05	DNPH1, MAFB	nucleoside deoxyribosyltransferase activity [MF], rhombomere 6 development [BP], deoxyribonucleoside 5'-monophosphate N-glycosidase activity [MF]
CG_ff_promoter_n_RM_12_47_15			3	1.0	2.23E-04	TUBB4A, CEP76, AZI1, LEF1, TUBGCP2, CHD8	G2/M transition of mitotic cell cycle [BP], armadillo repeat domain binding [MF]
CG_ff_promoter_n_RM_12_20_9			2	0.5	2.13E-04	HS6ST1, PLCD3, DRD1, DVL1	labyrinthine layer blood vessel development [BP], regulation of neurotransmitter levels [BP], prepulse inhibition [BP]
CG_ff_promoter_n_RM_12_376_6			2	0.5	3.04E-04	ITGB1	cell-cell adhesion mediated by integrin [BP]
CG_ff_promoter_n_RM_14_25_6			4	0.5	1.90E-04	EDN2	hormonal regulation of the force of heart contraction [BP]
CG_ff_promoter_n_RM_12_297_9			4	0.5	2.63E-04	KIF3A, BMP4	dorsal/ventral neural tube patterning [BP]
CG_ff_promoter_n_RM_12_186_14			2	0.5	1.38E-04	FOXA2, PRPSAP1, POU4F1	nucleotide biosynthetic process [BP], neuron fate specification [BP]
CG_ff_promoter_n_RM_12_411_9			2	0.5	2.34E-04	CXCL16	lymphocyte chemotaxis [BP]
CG_ff_promoter_n_RM_12_331_13			3	0.5	3.71E-04	TOB2	female gamete generation [BP]
CG_ff_promoter_n_RM_12_55_12			2	0.5	4.19E-04	CERKL, SOCS1, CERK, PTPN2	protein kinase C-activating G-protein coupled receptor signaling pathway [BP], diacylglycerol kinase activity [MF], regulation of interferon-gamma-mediated signaling pathway [BP]
CG_ff_promoter_n_RM_14_26_22			3	0.5	4.52E-04	SATB1, HIRA, U2AF1, TOP2B, BCL11A, SOX15, ZFHX3, HCN1, HSF2BP, DLX2, CDK6, CBX4, POFUT2, NCKAP1, NFIB	apical protein localization [BP], regulation of gene expression [BP], chromatin binding [MF], negative regulation of gene expression [BP], transcription from RNA polymerase II promoter [BP], regulation of transcription from RNA polymerase II promoter [BP]
CG_ff_promoter_n_RM_12_276_8			1	0.5	9.96E-05	PID1, MATN1	negative regulation of mitochondrial DNA replication [BP], growth plate cartilage chondrocyte morphogenesis [BP]
CG_ff_promoter_n_RM_12_59_13			3	0.5	3.17E-04	MED16, NCOA2	thyroid hormone receptor coactivator activity [MF]
CG_ff_promoter_n_RM_12_338_10			3	0.5	1.83E-04	KPNA3, HLCS	viral penetration into host nucleus [BP], biotin-protein ligase activity [MF], biotin-[methylcrotonoyl-CoA-carboxylase] ligase activity [MF], biotin-[methylmalonyl-CoA-carboxytransferase] ligase activity [MF], protein biotinylation [BP], biotin-[acetyl-CoA-carboxylase] ligase activity [MF], response to biotin [BP], biotin-[propionyl-CoA-carboxylase (ATP-hydrolyzing)] ligase activity [MF], histone biotinylation [BP]
CG_ff_promoter_n_RM_12_417_8			3	0.5	2.17E-04	TCF3	bHLH transcription factor binding [MF]
CG_ff_promoter_n_RM_12_312_12			3	0.5	2.52E-04	ALG12, MPPE1, PGAP3	GPI anchor metabolic process [BP], GPI anchor biosynthetic process [BP]
CG_ff_promoter_n_RM_12_147_10			3	0.5	1.91E-04	DCAF12, CUL3, FBXO31, PSMD12, CCNE2	cyclin binding [MF], protein ubiquitination [BP], cyclin catabolic process [BP], G1/S transition of mitotic cell cycle [BP]
CG_ff_promoter_n_RM_12_137_16			2	1.0	1.48E-04	COL16A1	collagen type XVI [CC]
CG_ff_promoter_n_RM_12_413_6			1	0.5	3.25E-04	NXF1, GRSF1	mRNA binding [MF]
CG_ff_promoter_n_RM_12_318_24			3	0.5	4.18E-04	ST3GAL1, MAN1A1, CDK6, NKX2-2	cellular protein modification process [BP], type B pancreatic cell development [BP], cellular protein metabolic process [BP]
CG_ff_promoter_n_RM_18_7_1			2	1.0	2.29E-04	ALDOB	fructose catabolic process [BP], vacuolar proton-transporting V-type ATPase complex assembly [BP], NADH oxidation [BP]
CG_ff_promoter_n_RM_14_21_7			2	1.0	5.72E-05	IFNA7, LPCAT1, IFNA4, SLC7A5	1-alkylglycerophosphocholine O-acetyltransferase activity [MF], blood coagulation [BP], negative regulation of phosphatidylcholine biosynthetic process [BP], regulation of type I interferon-mediated signaling pathway [BP], defense response to virus [BP], interferon-alpha/beta receptor binding [MF], type I interferon-mediated signaling pathway [BP]
CG_ff_promoter_n_RM_18_5_1			1	0.5	5.13E-04	HIST1H2BL, HIST1H4G, HIST1H1B, HIST1H1D	nucleosome assembly [BP], nucleosome [CC], DNA binding [MF], nuclear chromatin [CC]
CG_ff_promoter_n_RM_18_11_1			1	0.5	1.95E-04	ZNF681, ZNF737, ZNF708, ZNF506, ZNF117	transcription, DNA-dependent [BP], DNA binding [MF], regulation of transcription, DNA-dependent [BP], zinc ion binding [MF]
CG_ff_promoter_n_RM_12_354_8			1	0.5	1.08E-04	GALNS, SLC22A6	renal tubular secretion [BP], N-acetylgalactosamine-4-sulfatase activity [MF], N-acetylgalactosamine-6-sulfatase activity [MF]
CG_ff_promoter_n_RM_14_29_2			3	0.5	6.96E-04	HMGB1, COL2A1, CDK5, OVOL2, JAZF1	negative regulation of apoptotic cell clearance [BP], base-excision repair, DNA ligation [BP], negative regulation of RNA polymerase II transcriptional preinitiation complex assembly [BP], negative regulation of synaptic plasticity [BP], negative regulation of transcription, DNA-dependent [BP], regulation of gene expression [BP], cyclin-dependent protein kinase 5 holoenzyme complex [CC], collagen type II [CC], acetylcholine receptor activator activity [MF], transcriptional repressor complex [CC]
CG_ff_promoter_n_RM_12_22_9			4	0.5	7.09E-05	NRIP1, MTHFSD, TSC1, SLC6A20	ovarian follicle rupture [BP], rRNA export from nucleus [BP], glycine transport [BP], TSC1-TSC2 complex [CC], 5-formyltetrahydrofolate cyclo-ligase activity [MF]
CG_ff_promoter_n_RM_12_422_13			2	1.0	2.89E-04	DOLK	dolichyl monophosphate biosynthetic process [BP]
CG_ff_promoter_n_RM_12_248_11			3	0.5	2.81E-04	SEMA7A, SIX1, SIX2, NGF	middle ear morphogenesis [BP], positive regulation of axon extension [BP]
CG_ff_promoter_n_RM_14_40_4			3	0.5	2.91E-04	WNT2, TNNT2, DVL1, IGF2	receptor activator activity [MF], atrial cardiac muscle tissue morphogenesis [BP], frizzled binding [MF]
CG_ff_promoter_n_RM_12_49_12			3	0.5	1.55E-04	CEBPA, SNUPN, NKX2-2	ventral spinal cord interneuron fate determination [BP], snRNA import into nucleus [BP], response to vitamin B2 [BP], type B pancreatic cell fate commitment [BP]
CG_ff_promoter_n_RM_12_221_12			2	0.5	2.14E-04	CLOCK, SOX18	RNA polymerase II core promoter proximal region sequence-specific DNA binding [MF]
CG_ff_promoter_n_RM_12_14_11			4	1.0	3.45E-04	DKK3, ZNF33B, GSK3B, HOXA7, SALL1, SNAI3, CITED2, TFCP2L1, ALX4, FOXN3, STRN3	negative regulation of gene expression [BP], negative regulation of transcription, DNA-dependent [BP], adrenal gland development [BP], sequence-specific DNA binding transcription factor activity [MF]
CG_ff_promoter_n_RM_12_152_16			2	1.0	1.36E-04	UBC	hypothalamus gonadotrophin-releasing hormone neuron development [BP]
CG_ff_promoter_n_RM_12_84_11			1	0.5	3.11E-05	STAT6, CRLF3, HAND1, GJA5, HYAL2	gap junction channel activity involved in cardiac conduction electrical coupling [MF], cardiac septum morphogenesis [BP], atrial ventricular junction remodeling [BP], AV node cell to bundle of His cell communication by electrical coupling [BP], embryonic heart tube development [BP], positive regulation of transcription from RNA polymerase II promoter [BP], embryonic heart tube formation [BP], gap junction channel activity involved in AV node cell-bundle of His cell electrical coupling [MF], receptor signaling protein tyrosine kinase inhibitor activity [MF], regulation of transcription from RNA polymerase II promoter [BP]
CG_ff_promoter_n_RM_12_389_17			4	0.5	3.52E-04	H2AFX	condensed nuclear chromosome [CC], nuclear chromatin [CC]
CG_ff_promoter_n_RM_12_290_12			2	0.5	2.38E-04	CDK5	cerebellar cortex formation [BP]
CG_ff_promoter_n_RM_12_7_12			2	0.5	4.32E-04	BARHL2, ETHE1, ASPM	maintenance of centrosome location [BP], neuron migration [BP], negative regulation of asymmetric cell division [BP], sulfur dioxygenase activity [MF]
CG_ff_promoter_n_RM_14_62_4			2	0.5	2.87E-04	A4GALT, CHST10	lactosylceramide 4-alpha-galactosyltransferase activity [MF], HNK-1 sulfotransferase activity [MF]
CG_ff_promoter_n_RM_14_64_2			3	0.5	3.01E-04	HAND2, DSCAM	positive regulation of axon extension involved in axon guidance [BP], positive regulation of semaphorin-plexin signaling pathway involved in outflow tract morphogenesis [BP], positive regulation of transcription from RNA polymerase II promoter involved in norepinephrine biosynthetic process [BP]
CG_ff_promoter_n_RM_14_49_3			2	0.5	4.24E-04	TOLLIP	interleukin-18 receptor complex [CC]
CG_ff_promoter_n_RM_12_409_12			2	0.5	1.71E-04	IRF7, WIPI1	regulation of MyD88-independent toll-like receptor signaling pathway [BP], vesicle targeting, trans-Golgi to endosome [BP]
CG_ff_promoter_n_RM_12_109_21			2	0.5	1.85E-04	ADH4, QRFP	NADPH:quinone reductase activity [MF], benzaldehyde dehydrogenase activity [MF], orexigenic neuropeptide QRFP receptor binding [MF], alcohol dehydrogenase activity, zinc-dependent [MF], all-trans retinal binding [MF]
CG_ff_promoter_n_RM_12_117_17			3	1.0	1.27E-04	COL10A1, APOB, ARSD	mature chylomicron [CC], lysosome [CC], chylomicron remnant [CC], endoplasmic reticulum lumen [CC]
CG_ff_promoter_n_RM_12_57_15			2	0.5	4.11E-04	PAX6, GALC, ACTC1	pancreatic A cell development [BP], actomyosin, actin part [CC], commitment of neuronal cell to specific neuron type in forebrain [BP], regulation of transcription from RNA polymerase II promoter involved in somatic motor neuron fate commitment [BP], galactosylceramide catabolic process [BP], forebrain-midbrain boundary formation [BP], galactosylceramidase activity [MF]
CG_ff_promoter_n_RM_12_243_11			4	0.5	3.15E-04	RUNX1, CTGF, FLT4	positive regulation of progesterone secretion [BP], positive regulation of JNK cascade [BP]
CG_ff_promoter_n_RM_12_351_10			3	0.5	3.60E-04	UROC1, ACP2, DARS, SMAD7, ABCA5, NACC2, OSTM1	urocanate hydratase activity [MF], negative regulation of G1/S transition of mitotic cell cycle by negative regulation of transcription from RNA polymerase II promoter [BP], lysosomal membrane [CC], cellular protein complex localization [BP], aspartyl-tRNA aminoacylation [BP]
CG_ff_promoter_n_RM_12_115_13			2	1.0	1.32E-04	SRXN1, IL22	interleukin-22 receptor binding [MF], sulfiredoxin activity [MF]
CG_ff_promoter_n_RM_12_218_14			3	0.5	2.83E-04	NOX4, CYBA	superoxide-generating NADPH oxidase activity [MF], cellular response to gamma radiation [BP], superoxide anion generation [BP], NADPH oxidase complex [CC]
CG_ff_promoter_n_RM_12_375_19			2	0.5	4.20E-04	HLA-B, HLA-C	antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent [BP], MHC class I protein complex [CC], ER to Golgi transport vesicle membrane [CC], integral to lumenal side of endoplasmic reticulum membrane [CC], MHC class I receptor activity [MF]
CG_ff_promoter_n_RM_14_52_3			3	0.5	2.07E-04	ALKBH8	tRNA (uracil) methyltransferase activity [MF]
CG_ff_promoter_n_RM_12_183_10			1	0.5	1.49E-04	HIBCH	3-hydroxyisobutyryl-CoA hydrolase activity [MF]
CG_ff_promoter_n_RM_18_1_12			3	1.0	4.26E-04	GTF2E2, PJA2, SOS2, PRPF19, ZER1, TOP2A, ZNF367, TCEA1, TAF11, GSK3B, CACNG2, EVX2, POLR2I, LCORL, CUL2, ZZZ3, ZBTB2	DNA binding [MF], transcription elongation from RNA polymerase II promoter [BP], ionotropic glutamate receptor binding [MF], protein kinase A catalytic subunit binding [MF], Cul2-RING ubiquitin ligase complex [CC], positive regulation of viral transcription [BP], transcription from RNA polymerase II promoter [BP]
CG_ff_promoter_n_RM_12_265_11			4	1.0	2.77E-04	GAMT, HBEGF	guanidinoacetate N-methyltransferase activity [MF], negative regulation of elastin biosynthetic process [BP]
CG_ff_promoter_n_RM_12_398_5			2	0.5	2.49E-04	MYO1C, XPO4, CAMK1	myosin I complex [CC], positive regulation of protein export from nucleus [BP], motor activity [MF]
CG_ff_promoter_n_RM_14_66_2			2	0.5	5.78E-04	GALK1, ASCL2	negative regulation of Schwann cell proliferation [BP], spongiotrophoblast differentiation [BP], galactokinase activity [MF]
CG_ff_promoter_n_RM_14_47_3			3	0.5	2.95E-04	GRIK3, GRIN2C	glutamate receptor activity [MF], extracellular-glutamate-gated ion channel activity [MF], ionotropic glutamate receptor activity [MF]
CG_ff_promoter_n_RM_12_104_12			2	1.0	1.87E-04	MESP1, MCL1, CS	negative regulation of endodermal cell fate specification [BP], positive regulation of Notch signaling pathway involved in heart induction [BP], cell fate determination [BP], cardiac atrium formation [BP], cardioblast migration to the midline involved in heart field formation [BP], cardioblast anterior-lateral migration [BP], sinus venosus morphogenesis [BP], citrate (Si)-synthase activity [MF]
CG_ff_promoter_n_RM_12_51_11			2	1.0	1.44E-04	TRMT2B, CD74	macrophage migration inhibitory factor binding [MF], macrophage migration inhibitory factor receptor complex [CC], NOS2-CD74 complex [CC], macrophage migration inhibitory factor signaling pathway [BP], S-adenosylmethionine-dependent tRNA (m5U54) methyltransferase activity [MF]
CG_ff_promoter_n_RM_12_199_6			2	0.5	4.83E-04	ALAD, NDUFAB1	ACP phosphopantetheine attachment site binding involved in fatty acid biosynthetic process [MF], porphobilinogen synthase activity [MF], lead ion binding [MF]
CG_ff_promoter_n_RM_12_28_11			3	0.5	1.91E-04	CLGN, TOR1A, DNAJA2	unfolded protein binding [MF]
CG_ff_promoter_n_RM_12_169_15			2	0.5	2.66E-04	FGF8, DBN1	neural precursor cell proliferation [BP], midbrain-hindbrain boundary development [BP]
CG_ff_promoter_n_RM_18_14_1			1	0.5	1.70E-04	TAT	L-tyrosine:2-oxoglutarate aminotransferase activity [MF], L-phenylalanine:2-oxoglutarate aminotransferase activity [MF]
CG_ff_promoter_n_RM_12_373_11			3	0.5	3.25E-04	RRAGD, AXIN2, HOXA9, WASL, NACC2	cellular protein complex localization [BP], cellular protein localization [BP], definitive hemopoiesis [BP]
CG_ff_promoter_n_RM_12_170_7			1	0.5	3.66E-04	SFRP5	negative regulation of Wnt receptor signaling pathway involved in digestive tract morphogenesis [BP]
CG_ff_promoter_n_RM_14_6_10			4	0.5	2.12E-04	EEF1A2, KATNA1, CDK5, TNK2	neuronal cell body [CC]
CG_ff_promoter_n_RM_12_158_7			2	0.5	2.68E-04	PAX8, LIF	metanephric epithelium development [BP], mesenchymal to epithelial transition involved in metanephros morphogenesis [BP], regulation of metanephric nephron tubule epithelial cell differentiation [BP], positive regulation of mesenchymal to epithelial transition involved in metanephros morphogenesis [BP]
CG_ff_promoter_n_RM_14_69_2			2	0.5	7.03E-05	TAPT1	growth hormone-releasing hormone receptor activity [MF]
CG_ff_promoter_n_RM_12_394_8			3	0.5	2.74E-04	NUDT18	GDP catabolic process [BP], 8-oxo-dGDP phosphatase activity [MF], 8-oxo-GDP phosphatase activity [MF], dADP catabolic process [BP], dGDP catabolic process [BP], 8-hydroxy-dADP phosphatase activity [MF]
CG_ff_promoter_n_RM_12_288_17			2	0.5	3.98E-04	CDKN2B, AP2S1, CDKN2A, LRIG3, SFRP4, ITGB7, HRAS, RPL30, RPS2, KPNA1, TOB1, LEF1, BIN1, NPPC, ITGB1	regulation of endocytosis [BP], negative regulation of cell proliferation [BP], cell surface receptor signaling pathway [BP], viral reproduction [BP], cyclin-dependent protein kinase inhibitor activity [MF], regulation of protein export from nucleus [BP], multicellular organismal development [BP], anatomical structure regression [BP], intracellular protein transport [BP]
CG_ff_promoter_n_RM_12_97_25			4	1.0	1.56E-04	PTGES2, AP3D1, GOLGA3, NOTCH4	Golgi membrane [CC], intra-Golgi vesicle-mediated transport [BP]
CG_ff_promoter_n_RM_14_24_5			5	0.5	8.41E-06	C1QBP, H2AFY	positive regulation of mitochondrial translation [BP], mitochondrial ribosome binding [MF], Barr body [CC], negative regulation of MDA-5 signaling pathway [BP], positive regulation of trophoblast cell migration [BP], negative regulation of RIG-I signaling pathway [BP]
CG_ff_promoter_n_RM_12_200_11			2	0.5	2.78E-04	COL23A1, C1QTNF8	collagen [CC]
CG_ff_promoter_n_RM_14_96_2			2	0.5	3.36E-04	MKX, MYO10	tendon sheath development [BP], plus-end directed microfilament motor activity [MF]
CG_ff_promoter_n_RM_12_108_11			2	1.0	1.66E-04	INSRR, TNFSF14, LIPE	T cell homeostasis [BP], cellular response to alkalinity [BP], hormone-sensitive lipase activity [MF]
CG_ff_promoter_n_RM_12_151_6			1	0.5	3.88E-04	MAD2L2, ADCY6, GSK3A, AXIN1, ITPR2	energy reserve metabolic process [BP], beta-catenin destruction complex [CC], epidermal growth factor receptor signaling pathway [BP], negative regulation of canonical Wnt receptor signaling pathway [BP], protein phosphorylation [BP], fibroblast growth factor receptor signaling pathway [BP], cellular response to organic cyclic compound [BP], protein kinase binding [MF], negative regulation of Wnt receptor signaling pathway [BP], canonical Wnt receptor signaling pathway [BP], positive regulation of protein phosphorylation [BP]
CG_ff_promoter_n_RM_18_10_1			1	0.5	1.44E-04	ZNF737, ZNF626, ZNF681, ZNF98, ZNF99, ZNF708	transcription, DNA-dependent [BP], DNA binding [MF], regulation of transcription, DNA-dependent [BP], zinc ion binding [MF]
CG_ff_promoter_n_RM_12_267_17			3	0.5	3.93E-04	SOX15, RCOR2, SATB1, ELMSAN1, CBX4, DLX2, LOXL2	chromatin binding [MF]
CG_ff_promoter_n_RM_14_61_2			1	0.5	4.07E-04	ESRP2, CBS	homocysteine catabolic process [BP], cysteine biosynthetic process via cystathionine [BP], cerebellum morphogenesis [BP], regulation of RNA splicing [BP], cystathionine beta-synthase activity [MF], cysteine biosynthetic process from serine [BP]
CG_ff_promoter_n_RM_14_92_2			1	0.5	1.74E-04	IRF7	regulation of MyD88-independent toll-like receptor signaling pathway [BP]
CG_ff_promoter_n_RM_12_299_20			2	0.5	2.45E-04	AP3B1, PARD3, PCGF2, CBX8, NKX2-2	PRC1 complex [CC], protein phosphatase binding [MF], heterochromatin [CC], type B pancreatic cell development [BP], PcG protein complex [CC]
CG_ff_promoter_n_RM_14_28_4			3	0.5	3.67E-04	GAMT	guanidinoacetate N-methyltransferase activity [MF]
CG_ff_promoter_n_RM_14_33_13			5	1.0	2.70E-04	DDB1, PNKP, HMGB2	damaged DNA binding [MF]
CG_ff_promoter_n_RM_12_337_7			3	0.5	2.46E-04	PDLIM7, WNT10B, JUND, SHH, NKX2-6, NCOA2	osteoblast development [BP], ligand-dependent nuclear receptor binding [MF], tongue development [BP], positive regulation of osteoblast differentiation [BP]
CG_ff_promoter_n_RM_14_94_3			3	0.5	3.19E-04	TP53TG5, ZBTB5, EIF3A, ERCC2, PAX6, SALL1, REXO4, UBE2G1, MYBL1, UBE2V1, ZFP64, MLF2, MKX, KCTD1	protein K63-linked ubiquitination [BP], nucleic acid binding [MF], nucleus [CC]
CG_ff_promoter_n_RM_12_194_6			2	0.5	1.94E-04	HRAS, PAX8, MBD3, SMAD9, GCNT4	ureteric bud development [BP], urogenital system development [BP], organ morphogenesis [BP], thyroid hormone metabolic process [BP], tissue development [BP]
CG_ff_promoter_n_RM_12_285_15			2	0.5	3.33E-04	NOC2L, H2AFX, DNAJC1, POLG, SATB1, CBX8, NEUROG1, HIRA	chromatin binding [MF], histone binding [MF], nuclear chromatin [CC]
CG_ff_promoter_n_RM_14_98_5			1	0.5	7.34E-05	ZNF680, ZNF44, ZNF442, ZNF433, ZNF823	transcription, DNA-dependent [BP], DNA binding [MF], regulation of transcription, DNA-dependent [BP], zinc ion binding [MF]
CG_ff_promoter_n_RM_12_213_17			3	0.5	3.12E-04	FEV, LGI4	neuron maturation [BP]
CG_ff_promoter_n_RM_12_112_5			1	0.5	1.55E-04	GFM2, LBX1, AARS2, BAD, SLC16A8	lactate transport [BP], mitochondrial translation [BP], regulation of transcription from RNA polymerase II promoter involved in spinal cord association neuron specification [BP], lactate transmembrane transport [BP], cellular response to chromate [BP], lactate transmembrane transporter activity [MF], mitochondrial alanyl-tRNA aminoacylation [BP]
CG_ff_promoter_n_RM_12_26_13			2	0.5	2.23E-04	CTBP1, NFIB, JPH2	calcium-release channel activity [MF], RNA polymerase II transcription corepressor activity [MF]
CG_ff_promoter_n_RM_12_414_7			2	0.5	2.36E-04	NKX3-1, FGFR1, MSRB1	positive regulation of androgen secretion [BP], MADS box domain binding [MF], positive regulation of phosphatidylinositol 3-kinase cascade [BP], methionine-R-sulfoxide reductase activity [MF], salivary gland development [BP]
CG_ff_promoter_n_RM_12_224_14			2	0.5	3.09E-04	FUZ, LAMA5, HSP90AA1, AKT1	nitric-oxide synthase regulator activity [MF], embryo development [BP], hair follicle development [BP]
CG_ff_promoter_n_RM_12_249_20			3	0.5	3.94E-04	NOTCH1, PITX2	atrioventricular valve development [BP], left/right axis specification [BP], vascular smooth muscle cell differentiation [BP]
CG_ff_promoter_n_RM_12_236_11			4	0.5	3.31E-04	CALCOCO1, EVX2, FOXA1, ZNF837, MBD2, PITX2, LEF1, MNX1, WNT11, ZNF497	RNA polymerase II transcription regulatory region sequence-specific DNA binding transcription factor activity involved in positive regulation of transcription [MF], Wnt receptor signaling pathway [BP], armadillo repeat domain binding [MF], transcription regulatory region DNA binding [MF], sequence-specific DNA binding [MF], neuron fate specification [BP], pattern specification process [BP], DNA binding [MF], C2H2 zinc finger domain binding [MF], hypothalamus development [BP]
CG_ff_promoter_n_RM_12_128_54			6	1.0	1.42E-04	CITED1	response to interleukin-11 [BP]
CG_ff_promoter_n_RM_12_93_15			2	1.0	1.23E-04	NLRP10, AARS2	mitochondrial alanyl-tRNA aminoacylation [BP], helper T cell enhancement of adaptive immune response [BP]
CG_ff_promoter_n_RM_12_246_7			2	0.5	1.95E-04	LCAT, ST6GAL2	phosphatidylcholine-sterol O-acyltransferase activity [MF], beta-galactoside alpha-2,6-sialyltransferase activity [MF], regulation of high-density lipoprotein particle assembly [BP], apolipoprotein A-I binding [MF]
CG_ff_promoter_n_RM_12_62_6			2	1.0	6.80E-05	P4HB	endoplasmic reticulum-Golgi intermediate compartment [CC]
CG_ff_promoter_n_RM_12_410_6			2	0.5	3.16E-04	MAFB, SALL1, MB21D1, ICMT, TBX20	protein C-terminal S-isoprenylcysteine carboxyl O-methyltransferase activity [MF], cyclic-GMP-AMP synthase activity [MF], cardiac septum development [BP], embryonic heart tube elongation [BP], rhombomere 6 development [BP], inductive cell-cell signaling [BP]
CG_ff_promoter_n_RM_12_131_26			2	1.0	1.61E-04	TRPV6, AASS, RIT1, IMPAD1, SLC8A2, IFIH1	saccharopine dehydrogenase (NADP+, L-lysine-forming) activity [MF], single-stranded RNA binding [MF], saccharopine dehydrogenase (NAD+, L-glutamate-forming) activity [MF], 3'-nucleotidase activity [MF], calmodulin binding [MF]
CG_ff_promoter_n_RM_14_22_2			3	0.5	2.45E-04	GATM	glycine amidinotransferase activity [MF], creatine biosynthetic process [BP]
CG_ff_promoter_n_RM_12_298_6			3	0.5	5.05E-04	CD34, WNT11, OTX2, HMGB1	glomerular endothelium fenestra [CC], positive regulation of transforming growth factor beta production [BP], negative regulation of cellular response to hypoxia [BP], protein kinase activator activity [MF], extracellular vesicular exosome assembly [BP], sulfate binding [MF], endoderm development [BP], negative regulation of apoptotic cell clearance [BP], negative regulation of cellular response to heat [BP], positive regulation of glial cell line-derived neurotrophic factor secretion [BP]
CG_ff_promoter_n_RM_12_175_6			2	0.5	4.53E-04	NPC2	regulation of isoprenoid metabolic process [BP]
CG_ff_promoter_n_RM_12_330_21			3	0.5	3.20E-04	MLL2, PGAM2, MSC, POLR3K, CHD1, GBX2, LOXL2, LBR, H1FX, MEIS2, TRADD, TRDMT1, TBX18, MBD3, ARVCF, ZNF682, ZNF367, ANKRD34B, POLR2D, NACC2, SALL1, ZNF777, GMEB2, MEX3B, NEUROD2, UBTD2, TADA3, ACTL6B, ASCC3, PPP3CA, KDM5A, ZNF396, NUP88	chromatin modification [BP], NuRD complex [CC], ATP-dependent DNA helicase activity [MF], histone deacetylation [BP], nucleic acid binding [MF], chromatin organization [BP], DNA binding [MF], transcription from RNA polymerase II promoter [BP], nucleus [CC]
CG_ff_promoter_n_RM_12_171_9			4	0.5	4.21E-04	LEMD2	integral to nuclear inner membrane [CC]
CG_ff_promoter_n_RM_12_129_24			2	1.0	5.95E-05	NEK2	regulation of mitotic centrosome separation [BP]
CG_ff_promoter_n_RM_12_415_14			3	0.5	1.34E-04	BAD	positive regulation of mitochondrial membrane potential [BP], cellular response to chromate [BP]
CG_ff_promoter_n_RM_12_286_6			1	0.5	2.37E-04	PODXL	regulation of microvillus assembly [BP]
CG_ff_promoter_n_RM_12_173_8			3	0.5	3.45E-04	SLC30A3, EIF5A2	zinc transporting ATPase activity [MF], polyamine homeostasis [BP]
CG_ff_promoter_n_RM_12_68_8			2	0.5	2.64E-04	TBX5	pattern specification process [BP], cell migration involved in coronary vasculogenesis [BP]
CG_ff_promoter_n_RM_12_53_7			1	0.5	2.76E-04	VIPR2, DBN1	vasoactive intestinal polypeptide receptor activity [MF], cell communication by chemical coupling [BP]
CG_ff_promoter_n_RM_12_209_12			3	0.5	2.05E-04	HTR1B, DRD2	regulation of dopamine secretion [BP], response to cocaine [BP], negative regulation of cAMP biosynthetic process [BP], negative regulation of synaptic transmission, glutamatergic [BP], regulation of synaptic transmission, GABAergic [BP], G-protein coupled receptor internalization [BP]
CG_ff_promoter_n_RM_12_212_6			3	0.5	2.86E-04	ABCB6, SLC2A2	heme-transporting ATPase activity [MF], hexose transmembrane transport [BP]
CG_ff_promoter_n_RM_12_196_10			2	0.5	2.18E-04	GLI3, ZFP36L1, JAG2	thymic T cell selection [BP], T cell differentiation in thymus [BP]
CG_ff_promoter_n_RM_12_64_4			2	0.5	2.87E-04	PABPC1, GHRH, FTSJ2, SCRIB	rRNA (uridine-2'-O-)-methyltransferase activity [MF], growth hormone-releasing hormone receptor binding [MF], negative regulation of nuclear-transcribed mRNA catabolic process, nonsense-mediated decay [BP], rRNA methylation [BP], Scrib-APC-beta-catenin complex [CC]
CG_ff_promoter_n_RM_12_419_10			3	1.0	1.72E-04	IRS1, PRICKLE1	protein localization to nucleus [BP], negative regulation of cardiac muscle cell myoblast differentiation [BP]
CG_ff_promoter_n_RM_12_420_14			3	0.5	3.82E-04	CIZ1	positive regulation of DNA-dependent DNA replication initiation [BP], maintenance of nucleus location [BP]
CG_ff_promoter_n_RM_12_179_8			3	0.5	2.99E-04	CYP1A1, E2F7	hepatocyte differentiation [BP]
CG_ff_promoter_n_RM_12_139_14			3	1.0	1.52E-04	SHANK2, BBS7, MAPK1	protein complex [CC], cilium membrane [CC]
CG_ff_promoter_n_RM_12_132_8			1	0.5	1.52E-04	SLC30A2, BST2, CYP8B1	7alpha-hydroxycholest-4-en-3-one 12alpha-hydroxylase activity [MF], positive regulation of sequestering of zinc ion [BP], negative regulation of egress of virus within host cell [BP], negative regulation of plasmacytoid dendritic cell cytokine production [BP], sterol 12-alpha-hydroxylase activity [MF]
CG_ff_promoter_n_RM_12_110_16			2	1.0	1.13E-04	DBR1, CRLF1, ITPK1	inositol tetrakisphosphate 1-kinase activity [MF], inositol-1,3,4-trisphosphate 6-kinase activity [MF], RNA lariat debranching enzyme activity [MF], negative regulation of motor neuron apoptotic process [BP], inositol-1,3,4-trisphosphate 5-kinase activity [MF]
CG_ff_promoter_n_RM_12_223_15			2	0.5	2.70E-04	SIX1, TCP1, CXCR4, SHH, TPGS2, NDRG1, KIF21A, RCC2	patterning of blood vessels [BP], microtubule cytoskeleton [CC], ureter smooth muscle cell differentiation [BP], myelin maintenance [BP], positive regulation of oligodendrocyte differentiation [BP], positive regulation of mesenchymal cell proliferation involved in ureter development [BP], metanephric mesenchyme development [BP], microtubule [CC], thymus development [BP], thyroid gland development [BP], branching morphogenesis of an epithelial tube [BP]
CG_ff_promoter_n_RM_12_24_10			4	0.5	2.37E-04	MAP3K9, MAP4K5, JUN	activation of JUN kinase activity [BP], Rho GTPase activator activity [MF]
CG_ff_promoter_n_RM_12_262_8			2	0.5	4.40E-04	EPOR	erythropoietin receptor activity [MF]